WO2010006866A2 - Non-weighting hair treatment composition with structuring effects - Google Patents

Non-weighting hair treatment composition with structuring effects Download PDF

Info

Publication number
WO2010006866A2
WO2010006866A2 PCT/EP2009/057423 EP2009057423W WO2010006866A2 WO 2010006866 A2 WO2010006866 A2 WO 2010006866A2 EP 2009057423 W EP2009057423 W EP 2009057423W WO 2010006866 A2 WO2010006866 A2 WO 2010006866A2
Authority
WO
WIPO (PCT)
Prior art keywords
silicone
hair treatment
treatment composition
weight
composition according
Prior art date
Application number
PCT/EP2009/057423
Other languages
German (de)
French (fr)
Other versions
WO2010006866A3 (en
Inventor
Thorsten Knappe
Marcus Noll
Helga Flodrop Van
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2010006866A2 publication Critical patent/WO2010006866A2/en
Publication of WO2010006866A3 publication Critical patent/WO2010006866A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring

Definitions

  • the present invention relates to agents for treating keratinous fibers containing a combination of polymers with other specific ingredients.
  • keratinic fibers in principle, all animal hair, e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
  • animal hair e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
  • the keratinic fibers are human hairs.
  • Corresponding temporary shaping agents usually contain synthetic polymers as the shaping component.
  • Preparations containing a dissolved or dispersed polymer can be applied to the hair by means of propellant gases or by a pumping mechanism.
  • hair gels and hair waxes are generally not applied directly to the hair, but distributed by means of a comb or hands in the hair.
  • compositions for the temporary deformation of keratinic fibers also referred to below as styling agent
  • styling agent The most important property of a composition for the temporary deformation of keratinic fibers, also referred to below as styling agent, is to give the treated fibers in the produced form the strongest possible hold. If the keratin fibers are human hair, it is also referred to as a strong hairstyle or the high degree of retention of the styling agent. Of the Hairstyle hold is essentially determined by the type and amount of the synthetic polymer used, but an influence of the other constituents of the styling agent may also be present.
  • styling agents In addition to a high degree of hold, styling agents must meet a whole range of other requirements. These may be broad in properties on the hair, properties of the particular formulation, e.g. Properties of the foam, the gel or the sprayed aerosol, and properties that affect the handling of the styling agent, are subdivided, with the properties of the hair is of particular importance. Particularly noteworthy are moisture resistance, low tackiness and a balanced conditioning effect. Furthermore, a styling agent should be universally applicable as possible for all hair types.
  • the appearance of hair treated with hair-treatment products is at the center of consumer interest. So hair should be supple and shine while feeling soft and full.
  • the consumer expects the reversibility of the effects, i. a good washability of the products in order to be able to realize a different style if necessary.
  • Another problem is that subsequent treatments of the hair, such as dyeing or shaping, have worsened results due to the poorer washability of the silicone-containing compositions.
  • a first subject of the present invention is therefore a hair treatment composition containing in a suitable cosmetic carrier a) at least one silicone elastomer present in a silicone-based gel, b) at least one silicone-based water-in-oil emulsifier, characterized in that the weight ratio of silicone elastomer a) to silicone-based water-in-oil emulsifier b ) is greater than 1.
  • the agents according to the invention contain as the first compulsory component at least one silicone elastomer which is present in a silicone-based gel.
  • a preferred hair treatment agent is characterized in that the silicone elastomer a) is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 -C 10 alkenyl groups having terminal double bonds in each molecule with an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in has every molecule.
  • Hair treatment agents which are particularly preferred according to the invention are characterized in that the organopolysiloxane having at least 2 C 2 -C 10 -alkenyl groups having a terminal double bond in the molecule is selected from methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylpolysiloxanes, dimethylsiloxane-methylphenylsiloxane copolymers compounds with dimethylvinylsiloxy end groups, dimethylvinylsiloxy endblocked dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane
  • Hair treatment agents which are particularly preferred according to the invention are characterized in that the crosslinking organopolysiloxane having at least two silicon-bonded hydrogen atoms is selected from trimethylsiloxy-terminated methylhydrogenpolysiloxanes, trimethylsiloxy-endblocked dimethylsiloxane-methylhydrogensiloxane copolymers and cyclic dimethylsiloxane-methylhydrogen-siloxane copolymers.
  • Silicone elastomers which are particularly preferred according to the invention and are already pre-swollen as raw material in a silicone liquid at room temperature under normal conditions and are a silicone-based gel are commercially available, for example under the trade names SFE 168, a cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer from GE Silicones, vinyl Dimethicone cross polymers, contained in KSG-15 (cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 4 - 10 wt.%), KSG-16 (dimethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 20-30 wt -%), KSG-17 (cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer), KSG-18 (phenyl trimethicone (and) dimethicone /
  • Gransil ® series products from the Gransil ® series, especially Gransil SR-CYC (cyclomethicone and stearyl-vinyl / hydromethylsiloxane copolymer), Gransil RPS ® gel (INCI name: Cyclopentasiloxane and Polysilicone-11) Gransil GCM-4 ® (INCI name: Polysilicone-cyclotetrasiloxane and 11) Gransil GCM-5 ® (INCI name: Cyclopentasiloxane and Polysilicone-11), Gransil ® RPS (INCI name: Cyclopentasiloxane and Polysilicone-11), GI-CD 10 (INCI name: Cyclopentasiloxane (and) Stearoxymethicone / Dimethicone copolymer (and) Dimethicone), Gransil ® IDS (INCI name : Isododecane (and) cyclotet
  • Silicone elastomers a) which are already present as raw material in a liquid silicone at room temperature under normal conditions, mixed with a non-silicone-containing oil, fat or wax, and a silicone / non-silicone are also preferably used in the compositions according to the invention -based gel.
  • Such silicone elastomer compositions are also commercially available, for example under the trade name Gransil ® MLB (INCI name: Cyclopentasiloxane and Polysilicone-11 and Beeswax), Gransil PS ® (INCI designation voltage: cyclotetrasiloxane and polysilicone-11 and petrolatum), Gransil ® PS-5 (INCI name: Cyclopentasiloxane and Polysilicone-11 and petrolatum), Gransil ® DMG-20 P (with dimethicone 20 cst) and petrolatum (INCI designation: Dimethicone and polysilicone-11 and petrolatum), Gransil ® RJO (INCI name: Cyclopentasiloxane and polysilicone-11 and Jojoba Oil), Gransil ® LANO (INCI name: Cyclopentasiloxane and polysilicone-11 and lanolin), Gransil ® OHS 5 (INCI - Name: Cyclopent
  • silicone elastomer a) is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 -C 10 alkenyl groups having terminal double bond in each molecule with at least one alpha, omega-diene.
  • Particularly preferred alpha, omega-dienes are selected from 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, 1,7-octadiene, 1,8-nonadiene, 1,1-dodecadiene, 1, 13-tetradecadiene and 1, 19-eicosadiene.
  • a further preferred embodiment of the invention is characterized in that at least one of the silicone elastomers has emulsifying properties. It has surprisingly been found that the objects underlying this application have been solved particularly well; in particular the temperature stability of the compositions according to the invention could be improved.
  • the emulsifying properties are preferably obtainable with silicone elastomers of crosslinked organopolysiloxanes containing polyoxyethylene and / or polyoxypropylene groups as functional groups on the polysiloxane skeleton. These groups can be arranged terminally and / or as side groups to the polysiloxane chain.
  • particularly preferred non-emulsifying silicone elastomers b containing at least one ⁇ , omega-diene crosslinked organopolysiloxane in a silicone-based gel are commercially available, for example from Dow Corning the products DC 9040 (INCI name: Cyclomethicone (and) Dimethicone Crosspolymer, silicone elastomer content 12-14 wt .-%) and DC 9041 (INCI name: Dimethicone (and) Dimethicone Crosspolymer).
  • particularly preferred emulsifying silicone elastomers b containing at least one alpha, omega-diene crosslinked ethylene oxide-substituted organopolysiloxanes in a silicone-based gel are commercially available, for example from Dow Corning the products DC 9010 and DC 9011 (INCI name: Cyclopentasiloxane ( and) PEG-12 Dimethicone Crosspolymer).
  • Particularly preferred emulsifying silicone elastomers a which comprise crosslinked ethylene oxide-substituted organopolysiloxanes in a silicone-based gel are commercially available, for example the products KSG-21, KSG-31, KSG-31X and KSG-32 from Shin-Etsu.
  • the total amount of silicone elastomers is preferably within certain quantitative ranges.
  • another preferred embodiment of the invention is hair treatment compositions which contain the silicone elastomer (s) a present in a silicone-based gel (t / s) in a total amount of 0.05-20% by weight 0.5 to 15% by weight and more preferably 1 to 12.5% by weight, based in each case on the entire cosmetic composition.
  • silicone elastomers may vary the total amount of silicone elastomers depending on the product type. While hair styling agents such as hair sprays, hair gels, etc. are usually used in amounts of from 0.05 to 10% by weight, preferably from 0.1 to 9% by weight, more preferably from 0.25 to 8% by weight and in particular from 0, Containing 5 to 7.5 wt .-%, the elastomers are used in hair tip fluids or other concentrated care products in higher amounts. Hair care agents in the form of care fluids which are preferred according to the invention comprise the silicone elastomer (s) a present in a silicone-based gel (tVen), in a total amount of 2.5-20% by weight, preferably 5-17. 5% by weight and particularly preferably from 7.5 to 15% by weight, in each case based on the total fluid.
  • silicone elastomer (s) a present in a silicone-based gel (tVen) in a total amount of 2.5-20% by weight, preferably 5-17. 5% by weight and particularly
  • the weight ratio is the weight ratio of silicone elastomer a to water-in-oil emulsifier silicone-based b> 1.
  • the total amount of silicone elastomers in wt .-%, based on total agent
  • the total amount of water-in Silicone-based emulsifier in% by weight, based on total Shared.
  • Particularly preferred embodiments of the present invention are hair treatment compositions in which the weight ratio of silicone elastomer a to water-in-oil emulsifier silicone base b in the range of 1, 25- 50, preferably 1, 5-30 and particularly preferably 2-25, lies ,
  • ratios in the smaller of the ranges mentioned are usually selected, for example in the range from 1.1 to 40, preferably from 1.25 to 30, more preferably from 1.5 to 20 and in particular from 1.75 to 10.
  • the ratio is in higher ranges, for example in the range of 2 to 50, preferably 5 to 45, more preferably 10 to 40 and especially 15 to 30.
  • compositions of the invention contain at least one water-in-oil emulsifier based on silicone.
  • the at least one water-in-oil emulsifier based on silicone is preferably present in an amount of 0.05-10% by weight, preferably 0.1-5% by weight and in particular 0.5-2.5% by weight .-%, in each case based on the total weight of the inventive composition.
  • Hair-treatment agents which are preferred according to the invention are characterized in that they contain, as silicone-based water-in-oil emulsifier, organosiloxane-oxyalkylene copolymer (s) selected from compounds of the general structural formulas (I), (II), (III), (IV) and (V) included
  • radicals R 1 independently of one another represent a linear or branched C r C 30 -alkyl group or an optionally substituted phenyl group
  • radicals R 2 are independently of one another the groups -C c H 2c -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 or
  • radicals R 3 and R 4 independently of one another represent a linear or branched C 1 -C 16 -
  • radicals R 5 are independently a hydrogen atom or a linear or branched C r C 16 alkyl group and preferably a hydrogen atom or a
  • n is a number from O - 500
  • o is a number from 0-20
  • p is a number from 1-50
  • a is a number from 0-50
  • b is one Number represents from 0 to 50
  • a + b are at least 1
  • c represents a number from 1 to 4, particularly preferably 3
  • x represents a number from 1 to 100.
  • PEG / PPG-18/18 dimethicones which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C
  • PEG / PPG-4/12 dimethicone sold under the name Abil B 8852 is available
  • Bis-PEG / PPG-14/14 dimethicone which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt)
  • Bis-PEG / PPG-20/20 Dimethicone under the name Abil B 8832 is available
  • PEG / PPG-5/3 trisiloxanes (Silsoft 305)
  • PEG / PPG-20/23 dimethicones Silsoft 430 and Silsoft 440.
  • W / O emulsifiers are silicone-based poly (C 2 -C 3) alkylene glycol-modified silicones which are modified with C 4 -C 8 alkyl hydrophobic, more preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: Cetyl Dimethicone Copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, Cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols and alkyl dimethicones Ethoxy Glucosides.
  • silicone-based poly (C 2 -C 3) alkylene glycol-modified silicones which are modified with C 4 -C 8 alkyl hydrophobic, more preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: Cetyl Dimethicone Copolyol
  • organosiloxane-oxyalkylene copolymers as a water-in-oil emulsifier based on silicone, certain representatives are particularly preferred.
  • Hair treatment agents which are particularly preferred according to the invention are characterized in that they comprise as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I) in which
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning 190 (INCI: PEG / PPG-18/18 Dimethicone).
  • compositions according to the invention are characterized in that they contain at least one organosiloxane-oxyalkylene copolymer as silicone-based water-in-oil emulsifier of the general structural formula (I), wherein
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning 193 (INCI: PEG-12 Dimethicone).
  • organosiloxane-oxyalkylene Copolymer is available, for example, under the trade name Silwet L-77.
  • organosiloxane-oxyalkylene copolymer is obtainable, for example, in a mixture with cyclomethicone under the trade name Mirasil DCMO (INCI: Cyclomethicone, PEG / PPG-22/24 Dimethicone).
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning Q2-5220 (INCI: PEG / PPG-17/18 Dimethicone).
  • compositions according to the invention are characterized in that they contain as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I), wherein
  • Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 88184 (INCI: PEG / PPG-20/6 Dimethicone).
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 8851 (INCI: PEG / PPG-14/4 Dimethicone).
  • compositions according to the invention are characterized in that they contain as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (II), wherein
  • organosiloxane-oxyalkylene copolymer is obtainable, for example, in a mixture with cyclomethicones under the trade name Abil EM 97 (INCI: Bis-PEG / PPG-14/14 Dimethicone, Cyclomethicone).
  • Hair-treatment agents which are also preferred according to the invention are characterized in that they contain, as silicone-based water-in-oil emulsifier, at least one organosiloxane-oxyalkylene copolymer of the general structural formula (II) in which
  • R 1 methyl
  • R 2 -C c H 2o -O- (C 2 H 4 ⁇ -) a (C 3 H 6 O-) b
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 8832 (INCI: Bis-PEG / PPG-20/20 Dimethicone).
  • organosiloxane-oxyalkylene copolymers of general structural formula (I) which provide better release of the active ingredient than the organosiloxane-oxyalkylene copolymers of general structural formula (II).
  • compositions according to the invention are characterized in that the organosiloxane-oxyalkylene copolymer at 20 0 C has a water solubility of at least 5 g per 100 g of aqueous solution.
  • compositions according to the invention are characterized in that the organosiloxane-oxyalkylene copolymer has an HLB value in the range of 8-20, preferably 10-18, more preferably 11-16. Further preferred hair treatment compositions according to the invention are characterized in that at least one organosiloxane-oxyalkylene copolymer in a total amount of 0.01 to 5 wt .-%, preferably 0.1 to 4 wt .-%, particularly preferably in a total amount of 0.5 - 3 wt .-%, most preferably in a total amount of 1 - 2 wt .-%, is contained, each based on the total weight of the (propellant-free) composition.
  • compositions according to the invention may additionally contain at least one oil body.
  • oil bodies enhances the effects according to the invention, in particular the gloss of the hair treated with the agents according to the invention. Surprisingly, the abundance is further improved, although more of a weighting would be expected.
  • Preferred hair treatment compositions according to the invention are characterized in that they contain 1 to 20 wt .-%, preferably 2.5 to 17.5 wt .-% and in particular 5 to 12.5 wt .-% of at least one oil body.
  • Oil bodies which are preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated, the benzoic acid esters of linear or branched C 8 .
  • alkanols the C 8 -C 22 - Fettalkoholestern monovalent or polyvalent C 2 -C 7 hydroxycarboxylic acids, branched saturated or unsaturated fatty alcohols having 6 - 30 carbon atoms, dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, di-n alkyl ethers having a total of 12 to 36 carbon atoms.
  • compositions according to the invention preferably comprise at least one oil selected from the following groups:
  • esters of linear or branched saturated or unsaturated fatty alcohols having from 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having from 2 to 30 carbon atoms which may be hydroxylated include, preferably 2-ethylhexyl palmitate (z. B.
  • Cegesoft ® C 24 hexyldecyl stearate (Eutanol ® G 16), hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, Isononylstearat, isocetyl stearate , Isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanot, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palm
  • esters of monohydric or polyhydric C 2 -C 7 hydroxycarboxylic acids more preferably the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid and mixtures thereof.
  • di-C 12 -C 13 alkyl malate under the trademark Cosmacol ® by Nordmann, Rassmann GmbH & Co, Hamburg, refer, in particular the commercial products Cosmacol ® EMI, Cosmacol ® ESI and Cosmacol ® ETI;
  • the branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Particularly preferred oils are alcohol thereof, for example, hexyl decanol (for example Eutanol ® G.), Octyl dodecanol, and 2-ethylhexyl alcohol, and mixtures thereof;
  • Dicarboxylic acid esters of linear or branched C 2 -C 10 alkanols more preferably diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / dioctyl sebacate, Diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di (2-hexyldecyl) succinate, and mixtures thereof;
  • Di-n-alkyl ethers having a total of 12 to 36, in particular 12 to 24 carbon atoms, wherein di-n-octyl ether (eg., Cetiol ® OE), di-n-decyl ether, n-hexyl n-octyl ether and n-octyl-n-decyl ethers and mixtures thereof are particularly preferred.
  • di-n-octyl ether eg., Cetiol ® OE
  • Particularly preferred hair treatment agents of the invention are characterized by containing at least one ester of linear or branched saturated or unsaturated fatty alcohols having from 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having from 2 to 30 carbon atoms which may be hydroxylated propylisostearat from 2-ethylhexyl palmitate, hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl, isopropyl oleate, isooctyl stearate, Isononylstearat, isocetyl stearate, isononyl isononanoate, isotridec
  • Further particularly preferred hair treatment composition according to the invention are characterized in that they contain at least one benzoic acid esters of linear or branched C 8 _ 22 - of which alkanols selected from C 12 -C 15 alkyl benzoates, isostearyl benzoate and ethylhexyl benzoate and mixtures contain.
  • compositions according to the invention are characterized in that they contain at least one C 8 -C 22 fatty alcohol ester of monohydric or polyhydric C 2 -C 7 hydroxycarboxylic acids selected from the C 8 -C 22 fatty alcohol esters of glycolic acid, lactic acid, malic acid, tartaric acid , Citric acid and salicylic acid and mixtures thereof.
  • compositions according to the invention are characterized in that they contain at least one branched saturated or unsaturated fatty alcohol having 6 to 30 carbon atoms selected from hexyldecanol, octyldodecanol and 2-ethylhexyl alcohol and mixtures thereof.
  • compositions according to the invention are characterized in that they contain at least one dicarboxylic acid ester of linear or branched C 2 -C 10 -alkanols selected from diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / Di-n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate, and mixtures thereof.
  • dicarboxylic acid ester of linear or branched C 2 -C 10 -alkanols selected from diisopropyl adipate, di-n-butyl
  • compositions according to the invention are characterized in that they contain at least one di-n-alkyl ether having a total of 12 to 36 carbon atoms selected from di-n-octyl ether, di-n-decyl ether, n-hexyl n-octyl ether and n-octyl -n-decyl ethers and mixtures thereof.
  • agents according to the invention contain isopropyl myristate.
  • agents according to the invention which contain 2.5 to 20% by weight, preferably 5 to 15% by weight and in particular 7.5 to 11.0% by weight, of isopropyl myristate are preferred.
  • Particularly preferred agents according to the present invention include isopropyl myristate and a silicone-based water-in-oil emulsifier of the formula
  • the agents according to the invention contain all said ingredients in a cosmetically acceptable carrier.
  • Common cosmetically acceptable carriers are aqueous, alcoholic or aqueous-alcoholic media.
  • alcohols it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
  • Particularly preferred agents according to the invention are formulated with little or no water.
  • care products according to the invention such as hair tip fluids contain little to no water.
  • preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, less than 10% by weight, preferably less than 7.5% by weight, more preferably less than 5% by weight and in particular less than 2.5 Wt .-% water.
  • Particularly suitable as additional co-solvents are un branched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane.
  • particularly preferred water-soluble solvents are glycerol, ethylene glycol, butylene glycol and propylene glycol in an amount of up to 30 wt .-% based on the total agent.
  • agents according to the invention contain cyclic dimethicones.
  • agents according to the invention are preferred which additionally comprise at least one silicone of the formula Si-I
  • x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and especially 3, 4, 5 or 6.
  • compositions according to the invention contain, based on their weight, 10 to 80% by weight, preferably 20 to 77.5% by weight, more preferably 25 to 76% by weight and in particular 30 to 75% by weight of cyclopentasiloxane ,
  • compositions of the invention may further contain the auxiliaries and additives which are usually added to the respective cosmetic products.
  • the agent may contain, for example, at least one protein hydrolyzate and / or one of its derivatives.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess and Co), Lexein ® (Inolex) sericin (Pentapharm) and kerasol tm ® (Croda) sold.
  • silk protein hydrolysates By silk one understands the fibers of the cocoon of the mulberry silkworm (Bombyx mori L.).
  • the raw silk fiber consists of a double thread fibroin.
  • sericin holds this double thread together.
  • Silk consists of 70-80% by weight of fibroin, 19-28% by weight of sericin, 0.5-1% by weight of fat and 0.5-1% by weight of dyes and mineral constituents.
  • Protein hydrolysates of vegetable origin eg.
  • soybean almond, pea, potato and wheat protein hydrolysates, for example, under the trademarks Gluadin ® (Cognis), DiaMin ® (Diamalt) ® (Inolex), Hydrosoy (Croda), hydro Lupine (Croda), hydro Sesame (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
  • the protein hydrolysates are present in the agents according to the invention, for example, in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and very particularly preferably in amounts of 0 , 05 wt .-% up to 5 wt .-%, each based on the total application preparation included.
  • Cationic surfactants of the quaternary ammonium compounds, esterquats and amidoamines type are preferred according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An inventively particularly suitable compound from this group of substances under the name Tegoamid ® S 18 commercial stearamidopropyl dimethylamine is.
  • the cationic surfactants are contained in the compositions according to the invention preferably in amounts of from 0.05 to 10% by weight, based on the total application preparation. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Nurturing polymers are also suitable as a care substance. It should be noted at this point that some nourishing polymers also have film-forming and / or setting properties, and may therefore also be mentioned in the list of suitable film-forming and / or setting polymers.
  • a first group of caring polymers are the cationic polymers.
  • Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • “permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • such polymers in which the quaternary ammonium group are bonded via a C ⁇ -hydrocarbon group to a polymer main chain composed of acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • R 1 -H or -CH 3
  • R 2, R 3 and R 4 are independently selected from CI_ 4 alkyl, - alkenyl or hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n a natural number
  • X ' is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers.
  • those are preferred according to the invention for which at least one of the following conditions applies:
  • R 1 is a methyl group;
  • R 2 , R 3 and R 4 are methyl groups;
  • m has the value 2.
  • Suitable physiologically acceptable counterions X ' are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.
  • a particularly suitable homopolymer is, if desired, crosslinked, poly (meth acryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
  • the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylene bisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth-6)) commercially available.
  • Copolymers with monomer units of the formula (G1-I) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, acrylic acid C 1 -4 -alkyl esters and C 1 -4 -alkyl methacrylates. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. An inventively preferred copolymer is the crosslinked acrylamide-methacryloyloxyethyltrimethyl ammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
  • Celquat ® H 100, Celquat L 200 and Polymer JR ® ® 400 are preferred quaternized cellulose derivatives cationic alkyl polyglycosides according to DE-PS 44 13 686,
  • honey for example the commercial product Honeyquat ® 50,
  • Quaternary group polysiloxanes such as the commercially available products Q2-72424 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® quat 3270 and 3272 (manufacturer: Th Goldschmidt.), diquaternary polydimethylsiloxanes, quaternium-80)
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
  • Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers.
  • Gaffix ® VC 713 manufactured by ISP:
  • the copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
  • cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. Preferred are for example, chitosan and its derivatives, as they are freely available commercially, for example, under the trade names Hydagen ® CMF, Hydagen ® HCMF, Kytamer ® PC and Chitolam ® NB / 101.
  • cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ® 50, cationic Alkylpolyglycoside according to DE-PS 44 13 686 and polymers of the type Polyquaternium-37.
  • cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof.
  • the quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolysates may also be further derivatized.
  • cationic protein hydrolysates and derivatives those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 th Street, NW, Suite 300 Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Case
  • amphoteric polymers are those polymers which are composed essentially
  • n is an integer from 2 to 5 and A is the anion of an organic or inorganic acid
  • These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
  • Very particular preference is given to those polymers in which monomers of the type (a) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A () is a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (a).
  • Acrylic acid is preferably used as monomer (b) for the stated polymers.
  • the agents according to the invention preferably contain the caring, cationic and / or amphoteric polymers in an amount of from 0.01 to 5% by weight, in particular in an amount of from 0.1 to 2% by weight, in each case based on the total application preparation.
  • Further preferred agents according to the invention are characterized in that they additionally care substance (s) - in terms of their weight - in amounts of 0.001 to 10 wt .-%, preferably 0.005 to 7.5 wt .-%, particularly preferably 0.01 to 5 Wt .-% and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group i. L-carnitine and / or its salts; ii. Panthenol and / or panthothenic acid; iii. the 2-furanones and / or their derivatives, in particular pantolactone; iv. Taurine and / or its salts; v. niacinamide; vi. Ubiquinone vii. Ectoin; viii. Allantoin.
  • L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) - ⁇ /, ⁇ /, ⁇ / -trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance. It plays an essential role in the energy metabolism of human, animal and plant cells. L-carnitine can be obtained in various ways on an industrial scale. For example, a, the body's own biosynthesis imitating, biotechnological process: In large fermentation tanks while the precursor of L-carnitine ( ⁇ -butyrobetaine) using Gram-negative bacteria (rhizobia) in L-carnitine implemented.
  • L-carnitine can form addition compounds and double salts.
  • L-carnitine derivatives which are preferred according to the invention are selected in particular from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate.
  • the L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).
  • Preferred hair-cleansing compositions according to the invention are characterized in that they contain from -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight and in particular 0.05% by weight up to 2.5% by weight of L-carnitine or L-carnitine Carnitine derivatives containing preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.
  • Panthenol (ILJPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body.
  • Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).
  • Preferred hair-cleansing compositions according to the invention are characterized in that they contain -0.01 to 5% by weight, preferably 0.05 to 2.5% by weight, more preferably 0.1 to 1.5% by weight, based on their weight. % and in particular 0.25 to 1 wt .-% panthenol (( ⁇ ) -2,4-dihydroxy- ⁇ / - (3-hydroxypropyl) -3,3-dimethyl-butyramide).
  • Hair cleansers preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II)
  • radicals R 1 to R 10 are independently of one another
  • Di- or triaminocarbon radical a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated , branched or linear mono-, di- or
  • Trihydroxykohlenwasserstoffrest a group -NR 12 R 13 , wherein R 12 and R 13 each independently represent hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or Trihydroxykohlenwasserstoffrest, a group -COOR 14, wherein R 14 represents hydrogen, a methyl, a C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 - C 4 - saturated or on or diunsaturated, branched or linear mono, di or triamine hydrocarbon radical,
  • R 15 and R 16 each represent hydrogen, methyl, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triamine inokohlenwasserstoffrest, a group -COR 16 , where R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or
  • Hydrogen an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
  • radicals R 5 , R 6 , R 9 and R 10 in the active substance according to the formula (Fur I) and / or the formula (Fur II) according to the invention may furthermore be preferred for the radicals R 5 , R 6 , R 9 and R 10 in the active substance according to the formula (Fur I) and / or the formula (Fur II) according to the invention to be independently of one another
  • the compound corresponding to the formula (Fur-I) is (R) - (-) - 4-hydroxymethyl-T-butyrolactone and / or D, L-4-hydroxymethyl- ⁇ -butyrolactone and / or (S) - (+) - 4-hydroxymethyl- ⁇ -butyrolactone and / or R - (-) - 2-hydroxy-3,3-dimethyl- ⁇ -butyrolactone and / or D, L-2-hydroxy-3 , 3-dimethyl- ⁇ -butyrolactone and / or S (+) - 2-hydroxy-3,3-dimethyl- ⁇ -butyrolactone and / or 4-hydroxy-2,5-dimethyl-3 (2H) -furanone and / or tetrahydro-5-oxo-2-furancarboxylic acid and / or tetrahydro-5-oxo-2-furancarboxylic acid, Na-SaIz and / or t
  • hair cleansers preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).
  • Another preferred group of skin care enhancers in the compositions of the invention are vitamins, provitamins or vitamin precursors.
  • the agents according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, C, E and H.
  • Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinamide and biotin are particularly preferred. Very particular preference is given to using D-panthenol as care substance, if appropriate in combination with at least one of the abovementioned silicone derivatives.
  • the care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% at least a ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
  • n 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
  • the agents according to the invention may contain ectoin.
  • Ectoine ((4S) -2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes.
  • Agents according to the invention may preferably contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1% by weight .-% (S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically acceptable salts of this compound and / or (S, S) -5-hydroxy-2-methyl - 1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (hydroxyectoine) and the physiologically acceptable salts of this compound.
  • S -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid
  • hydroxyectoine hydroxyectoine
  • Allantoin is the final product of nucleic acid degradation, especially of purine, in various animal species, especially mammals, in addition to uric acid.
  • Compositions according to the invention optionally contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1% by weight .-% 5-ureido-hydantoin (allantoin).
  • compositions according to the invention may contain purine and / or purine derivatives as care-enhancing agents.
  • purine and / or purine derivatives with ubiquinones and / or plastoquinones as skin care enhancers means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.
  • Purine (7 / - / - imidazo [4,5-d] pyrimidine) does not occur freely in nature, but forms the main body of purines.
  • Purines are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH 2 , SH at the 2-, 6-, and 8-positions and / or with CH 3 in 1, 3, 7 position.
  • Purine can be prepared, for example, from aminoacetonitrile and formamide.
  • Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
  • Preferred agents according to the invention contain purine and / or purine derivatives in narrower quantitative ranges.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • preferred hair cleansers are characterized in that they are used as care enhancers - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt. % and in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s), wherein preferred agents purine and / or purine derivative (s) of the formula (Pur-I)
  • the agents according to the invention may also contain flavonoids.
  • the flavonoids are a group of water-soluble plant dyes and play an important role in the metabolism of many plants. They belong together with the phenolic acids to the polyphenols. There are well over 6500 different flavonoids known, which can be divided into flavonols, flavones, flavanones, isoflavonoids and anthocyanins.
  • flavonoids from all six groups can be used, with certain representatives from the individual groups being preferred as care enhancers because of their particularly intensive action.
  • Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin.
  • 2-pyrrolidinone-5-carboxylic acid and derivatives thereof are used as the carboxylic acid.
  • Particularly preferred are the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen one to three C r to C 4 - Carries alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the compositions according to the invention are preferably from 0.05 to 10% by weight, based on the total application preparation, particularly preferably from 0.1 to 5% by weight, and particularly preferably from 0.1 to 3% by weight.
  • UV filters By adding a UV filter, both the agents themselves and the treated fibers can be protected from the harmful effects of UV radiation.
  • at least one UV filter is added to the agent.
  • the UV filters preferred according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.
  • the UV filters are usually contained in amounts of 0.01-5 wt .-%, based on the total application preparation. Amounts of 0.1-2.5 wt .-% are preferred.
  • the agent according to the invention may be necessary for them to further contain at least one surfactant. This is especially true for hair cleansers and shampoos. But other means, such as hair rinses, hair treatments and certain styling agents, in particular styling foams, may contain surfactants.
  • cationic surfactants can be used, as described above as suitable care agents. With respect to the preferred cationic surfactants and the amounts used, the above statements apply accordingly.
  • the agents may contain other surfactants or emulsifiers, with both anionic and ampholytic and nonionic surfactants and all types of known emulsifiers being suitable in principle.
  • the group of ampholytic or amphoteric surfactants includes zwitterionic surfactants and ampholytes. The surfactants may already have emulsifying effect.
  • Suitable anionic surfactants are in principle all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • anionic surfactants are, in each case in the form of the sodium, potassium and ammonium and the mono-, di- and Trialkanolammoniumsalze with 2 to 4 carbon atoms in the alkanol group, linear and branched fatty acids having 8 to 30 carbon atoms (soaps), ether carboxylic acids of the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in the R is a linear alkyl group having 8 to 30 C.
  • Atoms and x 0 or 1 to 16 acylsarcosides having 8 to 24 carbon atoms in the acyl group, acyltaurides having 8 to 24 carbon atoms in the acyl group, acyl isethionates having 8 to 24 carbon atoms in the acyl group, sulfosuccinic mono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethyl esters having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 C-atoms, alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms, alkyl sulfates and alkyl polyglycol ether sulfates of the formula
  • Atoms and x 0 or 1 to 12
  • OX in the R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 1 or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6, independently of one another, represent hydrogen or a C 1 to C 4 hydrocarbon radical, is a sulfated fatty acid alkylene glycol ester of the formula (E1 -II)
  • R 8 CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for O or for numbers from 1 to 30, preferably 2 to 10, and X for an alkali or alkaline earth limetall is preferably monoglyceride sulfates of the formula (E1 -III) are used, in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms, amide ether carboxylic acids, condensation products of C 8 - C 30 - fatty alcohols with protein hydrolysates and / or amino acids and their derivatives, which are known to the skilled person as protein fatty acid condensates, such as Lamepon ® - types Gluadin ® - types Hostapon ® KCG or Amisoft ® - types.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having from 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having from 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethyl esters with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and protein fatty acid condensates.
  • Zwitterionic surfactants are surface-active compounds which have in the molecule at least one quaternary ammonium group and at least one -COO ( ⁇ '- or -SO 3' '' - Wear group
  • Particularly suitable zwitterionic surfactants are the betaines such as N-alkyl.
  • N, N-dimethylammonium glycinates for example the cocoalkyldimethylammonium glycineate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example the cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines
  • the preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name cocamidopropyl betaine.
  • Ampholytes are understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts.
  • ampholytes are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • Particularly preferred ampholytes are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 2 - C 8 - sarcosine.
  • Nonionic surfactants contain, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group as the hydrophilic group.
  • Such compounds are, for example Addition products of 2 to 50 moles of ethylene oxide and / or 1 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and on
  • Alkylphenols having 8 to 15 carbon atoms in the alkyl group, with a methyl or C 2 - C 6 - alkyl radical end facilitatorver fundamentally fundamental products of 2 to 50 moles of ethylene oxide and / or 1 to 5 moles of propylene oxide to linear and branched fatty alcohols with 8 to 30 C. Atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 carbon atoms.
  • alkyl group atoms such as those available under the brand names Dehydol ® LS
  • Polyol fatty acid esters such as the commercial product Hydagen ® HSP (Cognis) or
  • the alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol, and technical mixtures thereof which can be obtained as described above.
  • the preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are identified by the following parameters.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.
  • the other surfactants are generally in amounts of 0.1 to 45 wt .-%, preferably 0.5 to 30 wt .-% and most preferably from 0.5 to 25 wt .-%, based on the respective total Composition, used. The amount used depends essentially on the purpose of the agent according to the invention.
  • the agents may furthermore contain all active ingredients, additives and auxiliaries known for corresponding cosmetic agents.
  • composition was provided by mixing the respective components:
  • the resulting mixture was applied to the hair of a subject and left in the hair.
  • the hair received a velvety soft touch and gave the hairstyle structuring effect without being weight-bearing.
  • the subject's hair was washed after evaluation with a conventional shampoo.
  • the above recipe was easy to wash out.

Abstract

Hair treatment compositions which give the hair a soft, bouffant feel without weighing down the hairstyle, and which have pre-eminent rinse-out qualities, comprise, in a suitable cosmetic vehicle, at least one silicone elastomer, which is present in a silicone-based gel, and at least one silicone-based water-in-oil emulsifier, the weight ratio of silicone elastomer a to silicone-based water-in-oil emulsifier b being greater than 1.

Description

"Nicht beschwerendes Haarbehandlungsmittel mit strukturierenden Effekten " "Non-weighting hair treatment product with structuring effects"
Die vorliegende Erfindung betrifft Mittel zur Behandlung keratinischer Fasern, enthaltend eine Kombination von Polymeren mit weiteren speziellen Inhaltstoffen.The present invention relates to agents for treating keratinous fibers containing a combination of polymers with other specific ingredients.
Unter keratinischen Fasern werden prinzipiell alle tierischen Haare, z.B. Wolle, Rosshaar, Angora- haar, Pelze, Federn und daraus gefertigte Produkte oder Textilien verstanden. Vorzugsweise handelt es sich bei den keratinischen Fasern jedoch um menschliche Haare.Among keratinic fibers, in principle, all animal hair, e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them. Preferably, however, the keratinic fibers are human hairs.
Eine ansprechend aussehende Frisur wird heute allgemein als unverzichtbarer Teil eines gepflegten Äußeren angesehen. Dabei gelten aufgrund von aktuellen Modeströmungen immer wieder Frisuren als chic, die sich bei vielen Haartypen nur unter Verwendung festigender Wirkstoffe aufbauen bzw. für einen längeren Zeitraum bis hin zu mehreren Tagen aufrechterhalten lassen. Daher spielen Haarbehandlungsmittel, die einer permanenten oder temporären Formgebung der Haare dienen, eine wichtige Rolle. Temporäre Formgebungen, die einen guten Halt ergeben sollen, ohne das gesunde Aussehen der Haare, wie zum Beispiel deren Glanz, zu beeinträchtigen, können beispielsweise durch Haarsprays, Haarwachse, Haargele, Haarschäume, Fönwellen etc. erzielt werden.An attractive-looking hairstyle is now generally considered an indispensable part of a well-groomed appearance. Due to current fashion trends, hairstyles are always considered to be chic, which in many hair types can only be built up using firming agents or can be maintained for a longer period of time up to several days. Therefore, hair treatment agents that serve a permanent or temporary shaping of the hair play an important role. Temporary shapes that should give a good hold, without affecting the healthy appearance of the hair, such as their gloss, can be achieved for example by hair sprays, hair waxes, hair gels, hair mousses, hair drier, etc.
Entsprechende Mittel zur temporären Formgebung enthalten als formgebende Komponente üblicherweise synthetische Polymere. Zubereitungen, die ein gelöstes oder dispergiertes Polymer enthalten, können mittels Treibgasen oder durch einen Pumpmechanismus auf das Haar aufgebracht werden. Insbesondere Haargele und Haarwachse werden allerdings in der Regel nicht direkt auf das Haar appliziert, sondern mittels eines Kamms oder der Hände im Haar verteilt.Corresponding temporary shaping agents usually contain synthetic polymers as the shaping component. Preparations containing a dissolved or dispersed polymer can be applied to the hair by means of propellant gases or by a pumping mechanism. In particular, however, hair gels and hair waxes are generally not applied directly to the hair, but distributed by means of a comb or hands in the hair.
Die wichtigste Eigenschaft eines Mittels zur temporären Verformung keratinischer Fasern, im Folgenden auch Stylingmittel genannt, besteht darin, den behandelten Fasern in der erzeugten Form einen möglichst starken Halt zu geben. Handelt es sich bei den keratinischen Fasern um menschliche Haare, spricht man auch von starkem Frisurenhalt oder vom hohen Haltegrad des Stylingmittels. Der Frisurenhalt wird im Wesentlichen durch die Art und Menge des eingesetzten synthetischen Polymers bestimmt, wobei jedoch auch ein Einfluss der weiteren Bestandteile des Stylingmittels gegeben sein kann.The most important property of a composition for the temporary deformation of keratinic fibers, also referred to below as styling agent, is to give the treated fibers in the produced form the strongest possible hold. If the keratin fibers are human hair, it is also referred to as a strong hairstyle or the high degree of retention of the styling agent. Of the Hairstyle hold is essentially determined by the type and amount of the synthetic polymer used, but an influence of the other constituents of the styling agent may also be present.
Neben einem hohen Haltegrad müssen Stylingmittel eine ganze Reihe weiterer Anforderungen erfüllen. Diese können grob in Eigenschaften am Haar, Eigenschaften der jeweiligen Formulierung, z.B. Eigenschaften des Schaums, des Gels oder des versprühten Aerosols, und Eigenschaften, die die Handhabung des Stylingmittels betreffen, unterteilt werden, wobei den Eigenschaften am Haar besondere Wichtigkeit zukommt. Zu nennen sind insbesondere Feuchtebeständigkeit, niedrige Klebrigkeit und ein ausgewogener Konditioniereffekt. Weiterhin soll ein Stylingmittel möglichst für alle Haartypen universell einsetzbar sein.In addition to a high degree of hold, styling agents must meet a whole range of other requirements. These may be broad in properties on the hair, properties of the particular formulation, e.g. Properties of the foam, the gel or the sprayed aerosol, and properties that affect the handling of the styling agent, are subdivided, with the properties of the hair is of particular importance. Particularly noteworthy are moisture resistance, low tackiness and a balanced conditioning effect. Furthermore, a styling agent should be universally applicable as possible for all hair types.
Neben der Formgebung und dem Frisurenhalt ist auch das Aussehen der mit Haarbehandlungsmitteln behandelten Haare im Mittelpunkt des Verbraucherinteresses. So sollen Haare geschmeidig sein und glänzen und sich dabei weich und füllig anfühlen. Zudem erwartet der Verbraucher die Reversibilität der Effekte, d.h. eine gute Auswaschbarkeit der Produkte, um gegebenenfalls einen anderen Stil verwirklichen zu können.In addition to shaping and hairstyle, the appearance of hair treated with hair-treatment products is at the center of consumer interest. So hair should be supple and shine while feeling soft and full. In addition, the consumer expects the reversibility of the effects, i. a good washability of the products in order to be able to realize a different style if necessary.
Zur Pflege keratinischer Fasern enthalten viele Haarbehandlungsmittel Silikone. Diese verleihen den Haaren einen angenehmen Griff, weisen jedoch oft den Nachteil auf, daß sie die Frisur beschweren, die Haare strähnig und fettig aussehen lassen und zudem schwer auswaschbar sind.To care for keratinous fibers many hair treatment products contain silicones. These give the hair a pleasant grip, but often have the disadvantage that they complain the hairstyle, make the hair stringy and greasy look and are also difficult to wash out.
Ein weiteres Problem besteht darin, daß nachfolgende Behandlungen der Haare wie Färbungen oder Formgebung durch die schlechtere Auswaschbarkeit der silikonhaltigen Mittel verschlechterte Ergebnisse zeigen.Another problem is that subsequent treatments of the hair, such as dyeing or shaping, have worsened results due to the poorer washability of the silicone-containing compositions.
Aufgabe der vorliegenden Erfindung war es daher, Haarbehandlungsmittel bereitzustellen, die dem Haar ein weiches, fülliges Gefühl geben, ohne die Frisur zu beschweren. Dabei sollte besonderer Wert auf die Auswaschbarkeit der erfindungsgemäßen Mittel gelegt werden.It was therefore an object of the present invention to provide hair treatment compositions which give the hair a soft, full-bodied feel without complaining about the hairstyle. Particular importance should be attached to the washability of the compositions according to the invention.
Es wurde nunmehr überraschenderweise gefunden, daß sich die Kombination von Silikonelastomeren mit silikonhaltigen Emulgatoren zur Lösung dieser Aufgabe eignet.It has now surprisingly been found that the combination of silicone elastomers with silicone-containing emulsifiers is suitable for achieving this object.
Ein erster Gegenstand der vorliegenden Erfindung ist daher ein Haarbehandlungsmittel, enthaltend in einem geeigneten kosmetischen Träger a) mindestens ein Siliconelastomer, das in einem Silicon-basierten Gel vorliegt, b) mindestens einen Wasser-in-ÖI-Emulgator auf Siliconbasis, dadurch gekennzeichnet, daß das Gewichtsverhältnis von Siliconelastomer a) zu Wasser-in-ÖI- Emulgator auf Siliconbasis b) größer als 1 ist.A first subject of the present invention is therefore a hair treatment composition containing in a suitable cosmetic carrier a) at least one silicone elastomer present in a silicone-based gel, b) at least one silicone-based water-in-oil emulsifier, characterized in that the weight ratio of silicone elastomer a) to silicone-based water-in-oil emulsifier b ) is greater than 1.
Die erfindungsgemäßen Mittel enthalten als erste zwingende Komponente mindestens ein Siliconelastomer, das in einem Silicon-basierten Gel vorliegt.The agents according to the invention contain as the first compulsory component at least one silicone elastomer which is present in a silicone-based gel.
Ein bevorzugtes Haarbehandlungsmittel ist dadurch gekennzeichnet, daß das Siliconelastomere a) erhältlich ist durch die Vernetzung eines Organopolysiloxans, das mindestens 2 C2 - C10- Alkenylgruppen mit terminaler Doppelbindung in jedem Molekül enthält, mit einem Organopolysiloxan, das mindestens 2 Silicon-gebundene Wasserstoffatome in jedem Molekül aufweist.A preferred hair treatment agent is characterized in that the silicone elastomer a) is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 -C 10 alkenyl groups having terminal double bonds in each molecule with an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in has every molecule.
Erfindungsgemäß besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das Organopolysiloxan mit mindestens 2 C2 - C10-Alkenyl-Gruppen mit terminaler Doppelbindung im Molekül ausgewählt ist aus Methylvinylsiloxanen, Methylvinylsiloxan-Dimethylsiloxan-Copolymeren, Dimethylpolysiloxanen mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan-Methylphenylsiloxan- Copolymeren mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan-Diphenylsiloxan-Methylvinylsilo- xan-Copolymeren mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan-Methylvinylsiloxan-Copoly- meren mit Trimethylsiloxy-Endgruppen, Dimethylsiloxan-Methylphenylsiloxan-Methylvinylsiloxan- Copolymeren mit Trimethylsiloxy-Endgruppen, Methyl-(3,3,3-trifluoropropyl)-polysiloxanen mit Dimethylvinylsiloxy-Endgruppen und Dimethylsiloxan-Methyl-(3,3,3-trifluoropropyl)-siloxan-Copolyme- ren mit Dimethylvinylsiloxy-Endgruppen.Hair treatment agents which are particularly preferred according to the invention are characterized in that the organopolysiloxane having at least 2 C 2 -C 10 -alkenyl groups having a terminal double bond in the molecule is selected from methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylpolysiloxanes, dimethylsiloxane-methylphenylsiloxane copolymers compounds with dimethylvinylsiloxy end groups, dimethylvinylsiloxy endblocked dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, methyl (3,3, Dimethylvinylsiloxy-terminated 3-trifluoropropyl) -polysiloxanes and dimethylvinylsiloxy-terminated dimethylsiloxane-methyl- (3,3,3-trifluoropropyl) -siloxane copolymers.
Erfindungsgemäß besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das vernetzende Organopolysiloxan mit mindestens zwei Silicon-gebundenen Wasserstoffatomen ausgewählt ist aus Methylhydrogenpolysiloxanen mit Trimethylsiloxy-Endgruppen, Dimethylsiloxan- Methylhydrogensiloxan-Copolymeren mit Trimethylsiloxy-Endgruppen und cyclischen Dimethyl- siloxan-Methylhydrogen-Siloxan-Copolymeren.Hair treatment agents which are particularly preferred according to the invention are characterized in that the crosslinking organopolysiloxane having at least two silicon-bonded hydrogen atoms is selected from trimethylsiloxy-terminated methylhydrogenpolysiloxanes, trimethylsiloxy-endblocked dimethylsiloxane-methylhydrogensiloxane copolymers and cyclic dimethylsiloxane-methylhydrogen-siloxane copolymers.
Erfindungsgemäß besonders bevorzugte Siliconelastomere, die als Rohstoff bereits in einem bei Raumtemperatur unter Normalbedingungen flüssigen Silicon vorgequollen vorliegen und ein Siliconbasiertes Gel darstellen, sind kommerziell erhältlich, beispielsweise unter den Handelsnamen SFE 168, ein Cyclomethicone (and) Dimethicone/Vinyl Dimethicone Crosspolymer von GE Silicones, Vinyl Dimethicone Crosspolymere, enthalten in KSG-15 (Cyclomethicone (and) Dimethicone/Vinyl Dimethi- cone Crosspolymer, Siliconelastomergehalt 4 - 10 Gew.-%), KSG-16 (Dimethicone (and) Dimethicone/Vinyl Dimethicone Crosspolymer, Siliconelastomergehalt 20 - 30 Gew.-%), KSG-17 (Cyclomethicone (and) Dimethicone/Vinyl Dimethicone Crosspolymer), KSG-18 (Phenyl Trimethicone (and) Dimethicone/Phenyl Vinyl Dimethicone Crosspolymer, Siliconelastomergehalt 10 - 20 Gew.-%); and KSG-20, erhältlich von Shin Etsu Silicones of America (Akron, Ohio), und von Grant Industries Inc. (Elmwood Park, NJ) die Produkte aus der Gransil®-Serie, insbesondere Gransil SR-CYC (Cyclomethicone and Stearyl-Vinyl/hydromethylsiloxane Copolymer), Gransil® RPS Gel (INCI- Bezeichnung: Cyclopentasiloxane and Polysilicone-11 ), Gransil®GCM-4 (INCI-Bezeichnung: Cyclotetrasiloxane and Polysilicone-11 ), Gransil®GCM-5 (INCI-Bezeichnung: Cyclopentasiloxane and Polysilicone-11 ), Gransil® RPS (INCI-Bezeichnung: Cyclopentasiloxane and Polysilicone-11 ), GI-CD 10 (INCI-Bezeichnung: Cyclopentasiloxane (and) Stearoxymethicone/Dimethicone Copolymer (and) Dimethicone), Gransil® IDS (INCI-Bezeichnung: Isododecane (and) Cyclotetrasiloxane (and) Polysilicone-11 ), Gransil®PC-12 (INCI-Bezeichnung: Isododecane (and) Polysilicone-11 ), Gransil®IDS-5 (INCI-Bezeichnung: Isododecane (and) Cyclopentasiloxane (and) Polysilicone-11 ), Gransil®APK-1 (INCI-Bezeichnung: Dimethicone and Cyclopentasiloxane and Polysilicone-11 and Nylon-12 and Methyl Methacrylate/Acrylonitrile Copolymer and PEG-10 Dimethicone and Polysorbate-40 and Isohexadecane and Ammonium Polyacryloyldimethyl Taurate), Gransil®DMCM-5 (INCI-Bezeichnung: Dimethicone and Cyclopentasiloxane and Polysilicone-11 ), Gransil®DMG-6 mit Dimethicone (6 cSt) (INCI-Bezeichnung: Dimethicone and Polysilicone-11 ), Gransil®DMG-20 mit Dimethicone (20 cSt) (INCI-Bezeichnung: Dimethicone and Polysilicone-11 ), Gransil® AM-8 Gel (INCI-Bezeichnung: Caprylyl Methicone and Cyclopentasiloxane and Polysilicone-11 ), Gransil® DM 5 mit Dimethicone (5 cSt) (INCI-Bezeichnung: Dimethicone and Polysilicone-11 ), Gransil® DMID (INCI- Bezeichnung: Dimethicone and Isododecane and Polysilicone-11 ), Gransil® PM (INCI-Bezeichnung: Phenyl Trimethicone and Polysilicone-11 ), Gransil® ININ (INCI-Bezeichnung: Isononyl Isononanoate (and) Polysilicone-11 ).Silicone elastomers which are particularly preferred according to the invention and are already pre-swollen as raw material in a silicone liquid at room temperature under normal conditions and are a silicone-based gel are commercially available, for example under the trade names SFE 168, a cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer from GE Silicones, vinyl Dimethicone cross polymers, contained in KSG-15 (cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 4 - 10 wt.%), KSG-16 (dimethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 20-30 wt -%), KSG-17 (cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer), KSG-18 (phenyl trimethicone (and) dimethicone / phenyl vinyl dimethicone crosspolymer, silicone elastomer content 10-20 wt%); and KSG-20 available from Shin Etsu Silicones of America (Akron, Ohio), and Grant Industries Inc. (Elmwood Park, NJ) products from the Gransil ® series, especially Gransil SR-CYC (cyclomethicone and stearyl-vinyl / hydromethylsiloxane copolymer), Gransil RPS ® gel (INCI name: Cyclopentasiloxane and Polysilicone-11) Gransil GCM-4 ® (INCI name: Polysilicone-cyclotetrasiloxane and 11) Gransil GCM-5 ® (INCI name: Cyclopentasiloxane and Polysilicone-11), Gransil ® RPS (INCI name: Cyclopentasiloxane and Polysilicone-11), GI-CD 10 (INCI name: Cyclopentasiloxane (and) Stearoxymethicone / Dimethicone copolymer (and) Dimethicone), Gransil ® IDS (INCI name : Isododecane (and) cyclotetrasiloxane (and) polysilicone-11), Gransil ® PC-12 (INCI name: Isododecane (and) polysilicone-11), Gransil ® IDS-5 (INCI name: Isododecane (and) Cyclopentasiloxane (and ) Polysilicone-11), Gransil ® APK-1 (INCI designation: Dimethicone to d Cyclopentasiloxane and Polysilicone-11 and nylon-12 and Methyl Methacrylate / Acrylonitrile copolymer and PEG-10 Dimethicone and Polysorbate-40 and Isohexadecane and ammonium Polyacryloyldimethyl taurates), Gransil ® DMCM-5 (INCI name: Dimethicone and Cyclopentasiloxane and Polysilicone-11 ), Gransil ® DMG-6 (with dimethicone 6 cSt) (INCI name: dimethicone and polysilicone-11), Gransil ® DMG-20 (with dimethicone 20 cst) (INCI name: dimethicone and polysilicone-11), Gransil ® AM-8 gel (INCI name: Caprylyl Methicone and Cyclopentasiloxane and Polysilicone-11), Gransil ® DM 5 with Dimethicone (5 cSt) (INCI name: dimethicone and polysilicone-11), Gransil ® DMID (INCI name: Dimethicone and Isododecane and Polysilicone-11), Gransil PM ® (INCI name: Polysilicone-phenyl Trimethicone and 11), Gransil ® ININ (INCI name: isononyl Isononanoate (and) Polysilicone-11).
Ebenfalls mit Vorzug in den erfindungsgemäßen Zusammensetzungen einsetzbar sind Siliconelastomere a), die als Rohstoff bereits in einem bei Raumtemperatur unter Normalbedingungen flüssigen Silicon, gemischt mit einem Nicht-Silicon-haltigen Öl, Fett oder Wachs, vorgequollen vorliegen und ein Silicon-/Nicht-Silicon-basiertes Gel darstellen. Derartige Siliconelastomer-Zusammensetzungen sind ebenfalls kommerziell erhältlich, beispielsweise unter den Handelsnamen Gransil® MLB (INCI- Bezeichnung: Cyclopentasiloxane and Polysilicone-11 and Beeswax), Gransil® PS (INCI-Bezeich- nung: Cyclotetrasiloxane and Polysilicone-11 and Petrolatum), Gransil® PS-5 (INCI-Bezeichnung: Cyclopentasiloxane and Polysilicone-11 and Petrolatum), Gransil®DMG-20 P mit Dimethicone (20 cSt) und Petrolatum (INCI-Bezeichnung: Dimethicone and Polysilicone-11 and Petrolatum), Gransil® RJO (INCI-Bezeichnung: Cyclopentasiloxane and Polysilicone-11 and Jojoba OiI), Gransil® LANO (INCI-Bezeichnung: Cyclopentasiloxane and Polysilicone-11 and Lanolin), Gransil® OHS-5 (INCI- Bezeichnung: Cyclopentasiloxane and Polysilicone-11 and Octyl Hydroxystearate) und Gransil® DML (INCI-Bezeichnung: Dimethicone (and) Neopentyl Glycol Diheptanoate (and) Polysilicone-11 ).Silicone elastomers a) which are already present as raw material in a liquid silicone at room temperature under normal conditions, mixed with a non-silicone-containing oil, fat or wax, and a silicone / non-silicone are also preferably used in the compositions according to the invention -based gel. Such silicone elastomer compositions are also commercially available, for example under the trade name Gransil ® MLB (INCI name: Cyclopentasiloxane and Polysilicone-11 and Beeswax), Gransil PS ® (INCI designation voltage: cyclotetrasiloxane and polysilicone-11 and petrolatum), Gransil ® PS-5 (INCI name: Cyclopentasiloxane and Polysilicone-11 and petrolatum), Gransil ® DMG-20 P (with dimethicone 20 cst) and petrolatum (INCI designation: Dimethicone and polysilicone-11 and petrolatum), Gransil ® RJO (INCI name: Cyclopentasiloxane and polysilicone-11 and Jojoba Oil), Gransil ® LANO (INCI name: Cyclopentasiloxane and polysilicone-11 and lanolin), Gransil ® OHS 5 (INCI - Name: Cyclopentasiloxane and Polysilicone-11 and Octyl Hydroxystearate) and Gransil ® DML (INCI name: Dimethicone (and) Neopentyl Glycol Diheptanoate (and) Polysilicone-11).
Ein weiteres bevorzugtes Haarbehandlungsmittel ist dadurch gekennzeichnet, daß das Siliconelastomere a) durch die Vernetzung eines Organopolysiloxans, das mindestens 2 C2 - C10- Alkenylgruppen mit terminaler Doppelbindung in jedem Molekül enthält, mit mindestens einem alpha, omega-Dien erhältlich ist.Another preferred hair treatment agent is characterized in that the silicone elastomer a) is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 -C 10 alkenyl groups having terminal double bond in each molecule with at least one alpha, omega-diene.
Erfindungsgemäß besonders bevorzugte vernetzende alpha, omega-Diene weisen die Formel CH2=CH(CH2)XCH=CH2 mit x = 1 - 20 auf. Besonders bevorzugte alpha, omega-Diene sind ausgewählt aus 1 ,4-Pentadien, 1 ,5-Hexadien, 1 ,6- Heptadien, 1 ,7-Octadien, 1 ,8-Nonadien, 1 ,11-Dode- cadien, 1 ,13-Tetradecadien und 1 ,19- Eicosadien.Crosslinking alpha, omega-dienes which are particularly preferred according to the invention have the formula CH 2 = CH (CH 2 ) X CH = CH 2 where x = 1 to 20. Particularly preferred alpha, omega-dienes are selected from 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, 1,7-octadiene, 1,8-nonadiene, 1,1-dodecadiene, 1, 13-tetradecadiene and 1, 19-eicosadiene.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, daß mindestens eines der Siliconelastomere emulgierende Eigenschaften aufweist. Es wurde überraschend festgestellt, daß die dieser Anmeldung zugrunde liegenden Aufgaben dadurch besonders gut gelöst wurden; insbesondere die Temperaturstabilität der erfindungsgemäßen Zusammensetzungen konnte verbessert werden. Die emulgierenden Eigenschaften sind bevorzugt erhältlich mit Siliconelastomeren aus vernetzten Organopolysiloxanen, die am Polysiloxan-Gerüst Polyoxyethylen- und/oder Polyoxypropylen-Gruppen als funktionelle Gruppen enthalten. Diese Gruppen können endständig und/ oder als Seitengruppen zur Polysiloxan-Kette angeordnet sein.A further preferred embodiment of the invention is characterized in that at least one of the silicone elastomers has emulsifying properties. It has surprisingly been found that the objects underlying this application have been solved particularly well; in particular the temperature stability of the compositions according to the invention could be improved. The emulsifying properties are preferably obtainable with silicone elastomers of crosslinked organopolysiloxanes containing polyoxyethylene and / or polyoxypropylene groups as functional groups on the polysiloxane skeleton. These groups can be arranged terminally and / or as side groups to the polysiloxane chain.
Erfindungsgemäß können sowohl nicht-emulgierende als auch emulgierende Siliconelastomere sowie deren Mischungen eingesetzt werden.Both non-emulsifying and emulsifying silicone elastomers and mixtures thereof can be used according to the invention.
Erfindungsgemäß besonders bevorzugte nicht-emulgierende Siliconelastomere b, die mit mindestens einem alpha, omega-Dien vernetzte Organopolysiloxane in einem Silicon-basierten Gel enthalten, sind im Handel erhältlich, beispielsweise von Dow Corning die Produkte DC 9040 (INCI-Bezeichnung: Cyclomethicone (and) Dimethicone Crosspolymer, Siliconelastomergehalt 12 - 14 Gew.-%) und DC 9041 (INCI-Bezeichnung: Dimethicone (and) Dimethicone Crosspolymer).According to the invention, particularly preferred non-emulsifying silicone elastomers b containing at least one α, omega-diene crosslinked organopolysiloxane in a silicone-based gel are commercially available, for example from Dow Corning the products DC 9040 (INCI name: Cyclomethicone (and) Dimethicone Crosspolymer, silicone elastomer content 12-14 wt .-%) and DC 9041 (INCI name: Dimethicone (and) Dimethicone Crosspolymer).
Erfindungsgemäß besonders bevorzugte emulgierende Siliconelastomere b, die mit mindestens einem alpha, omega-Dien vernetzte Ethylenoxid-substituierte Organopolysiloxane in einem Siliconbasierten Gel enthalten, sind im Handel erhältlich, beispielsweise von Dow Corning die Produkte DC 9010 und DC 9011 (INCI-Bezeichnung: Cyclopentasiloxane (and) PEG-12 Dimethicone Crosspolymer).According to the invention particularly preferred emulsifying silicone elastomers b containing at least one alpha, omega-diene crosslinked ethylene oxide-substituted organopolysiloxanes in a silicone-based gel are commercially available, for example from Dow Corning the products DC 9010 and DC 9011 (INCI name: Cyclopentasiloxane ( and) PEG-12 Dimethicone Crosspolymer).
Erfindungsgemäß besonders bevorzugte emulgierende Siliconelastomere a, die vernetzte Ethylenoxid-substituierte Organopolysiloxane in einem Silicon-basierten Gel enthalten, sind im Handel erhältlich, beispielsweise die Produkte KSG-21 , KSG-31 , KSG-31X und KSG-32 von Shin-Etsu.Particularly preferred emulsifying silicone elastomers a which comprise crosslinked ethylene oxide-substituted organopolysiloxanes in a silicone-based gel are commercially available, for example the products KSG-21, KSG-31, KSG-31X and KSG-32 from Shin-Etsu.
Unabhängig davon, ob nur ein Silikonelastomer oder mehrere verschiedene Silikonelastomere in den erfindungsgemäßen Mitteln enthalten sind, liegt die Gesamtmenge an Silikonelastomeren vorzugsweise innerhalb bestimmter Mengenbereiche. Eine weitere bevorzugte Ausführungsform der Erfindung sind daher Haarbehandlungsmittel, die das/die Siliconelastomer(e) a, das/die in einem Silicon-basierten Gel vorlieg(t/en), in einer Gesamtmenge von 0,05 - 20 Gew.%, bevorzugt 0,5 - 15 Gew.% und besonders bevorzugt 1 - 12,5 Gew.%, jeweils bezogen auf die gesamte kosmetische Zusammensetzung, enthalten.Regardless of whether only one silicone elastomer or several different silicone elastomers are contained in the compositions according to the invention, the total amount of silicone elastomers is preferably within certain quantitative ranges. Thus, another preferred embodiment of the invention is hair treatment compositions which contain the silicone elastomer (s) a present in a silicone-based gel (t / s) in a total amount of 0.05-20% by weight 0.5 to 15% by weight and more preferably 1 to 12.5% by weight, based in each case on the entire cosmetic composition.
Dabei kann die die Gesamtmenge an Silikonelastomeren je nach Produkttyp variieren. Während Haarstylingmittel wie Haarsprays, Haargele usw. üblicherweise Mengen von 0,05 bis 10 Gew.-%, vorzugsweise von 0,1 bis 9 Gew.-%, weiter bevorzugt von 0,25 bis 8 Gew.-% und insbesondere von 0,5 bis 7,5 Gew.-% enthalten, werden die Elastomere in Haarspitzenfluids oder anderen konzentrierten Pflegeprodukten in höheren Mengen eingesetzt. Erfindungsgemäß bevorzugte Haarbehandlungsmittel in Form von Pflegefluids enthalten das/die Siliconelastomer(e) a, das/die in einem Silicon-basierten Gel vorlieg(tVen), in einer Gesamtmenge von 2,5 - 20 Gew.%, bevorzugt von 5 - 17,5 Gew.% und besonders bevorzugt von 7,5 - 15 Gew.%, jeweils bezogen auf das gesamte Fluid.It may vary the total amount of silicone elastomers depending on the product type. While hair styling agents such as hair sprays, hair gels, etc. are usually used in amounts of from 0.05 to 10% by weight, preferably from 0.1 to 9% by weight, more preferably from 0.25 to 8% by weight and in particular from 0, Containing 5 to 7.5 wt .-%, the elastomers are used in hair tip fluids or other concentrated care products in higher amounts. Hair care agents in the form of care fluids which are preferred according to the invention comprise the silicone elastomer (s) a present in a silicone-based gel (tVen), in a total amount of 2.5-20% by weight, preferably 5-17. 5% by weight and particularly preferably from 7.5 to 15% by weight, in each case based on the total fluid.
Erfindungsgemäß beträgt das Gewichtsverhältnis Gewichtsverhältnis von Siliconelastomer a zu Wasser-in-ÖI-Emulgator auf Siliconbasis b > 1. Zur Ermittlung dieses Zahlenwertes wird die Gesamtmenge an Silikonelastomeren (in Gew.-%, bezogen auf gesamtes Mittel) durch die Gesamtmenge an Wasser-in-ÖI-Emulgator auf Siliconbasis (in Gew.-%, bezogen auf gesamtes Mittel) geteilt. Auch bei diesem Verhältnis hängt die Wahl bevorzugter Werte von der Art des Haarbehandlungsmittels ab.According to the invention, the weight ratio is the weight ratio of silicone elastomer a to water-in-oil emulsifier silicone-based b> 1. To determine this numerical value, the total amount of silicone elastomers (in wt .-%, based on total agent) by the total amount of water-in Silicone-based emulsifier (in% by weight, based on total Shared). Even with this ratio, the choice of preferred values depends on the type of hair treatment agent.
Besonders bevorzugte Ausführungsformen der vorliegenden Erfindung sind Haarbehandlungsmittel, bei denen das Gewichtsverhältnis von Siliconelastomer a zu Wasser-in-ÖI-Emulgator auf Siliconbasis b im Bereich von 1 ,25 - 50, bevorzugt 1 ,5 - 30 und besonders bevorzugt 2 - 25, liegt.Particularly preferred embodiments of the present invention are hair treatment compositions in which the weight ratio of silicone elastomer a to water-in-oil emulsifier silicone base b in the range of 1, 25- 50, preferably 1, 5-30 and particularly preferably 2-25, lies ,
Bei Haarstylingmitteln wie Haarsprays, Haargelen usw. werden üblicherweise Verhältnisse im kleineren der genannten Bereiche gewählt, beispielsweise im Bereich von 1 ,1 bis 40, vorzugsweise von 1 ,25 bis 30, weiter bevorzugt von 1 ,5 bis 20 und insbesondere von 1 ,75 bis 10. In Haarspitzenfluids oder anderen konzentrierten Pflegeprodukten liegt das Verhältnis in höheren Bereichen, beispielsweise im Bereich von 2 bis 50, vorzugsweise von 5 bis 45, weiter bevorzugt von 10 bis 40 und insbesondere von 15 bis 30.For hair styling agents such as hair sprays, hair gels etc., ratios in the smaller of the ranges mentioned are usually selected, for example in the range from 1.1 to 40, preferably from 1.25 to 30, more preferably from 1.5 to 20 and in particular from 1.75 to 10. In hairspray fluids or other concentrated care products, the ratio is in higher ranges, for example in the range of 2 to 50, preferably 5 to 45, more preferably 10 to 40 and especially 15 to 30.
Als zweiten wesentlichen Bestandteil enthalten die erfindungsgemäßen Mittel mindestens einen Wasser-in-ÖI-Emulgator auf Siliconbasis.As a second essential ingredient, the compositions of the invention contain at least one water-in-oil emulsifier based on silicone.
Der mindestens eine Wasser-in-ÖI-Emulgator auf Siliconbasis ist bevorzugt in einer Menge von 0,05 - 10 Gew.-%, vorzugsweise von 0,1 - 5 Gew.-% und insbesondere von 0,5 - 2,5 Gew.-%, jeweils bezogen auf das Gesamtgewicht des erfindungsgemäßen Mittels, enthalten.The at least one water-in-oil emulsifier based on silicone is preferably present in an amount of 0.05-10% by weight, preferably 0.1-5% by weight and in particular 0.5-2.5% by weight .-%, in each case based on the total weight of the inventive composition.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis Organosiloxan-Oxyalkylen-Copolymer(e), ausgewählt aus Verbindungen der allgemeinen Strukturformeln (I), (II), (III), (IV) und (V) enthaltenHair-treatment agents which are preferred according to the invention are characterized in that they contain, as silicone-based water-in-oil emulsifier, organosiloxane-oxyalkylene copolymer (s) selected from compounds of the general structural formulas (I), (II), (III), (IV) and (V) included
CH3 CH3 CH3 CH3 CH 3 CH 3 CH 3 CH 3
R1-Si— O- -Si-O Si- -O -Si-R1 CH, CH, CH,R 1 -Si-O- -Si-O-Si - O - -Si-R 1 CH, CH, CH,
(I)(I)
CH3 CH3 CH3 CH3 CH 3 CH 3 CH 3 CH 3
R2-Si— O- -Si-O Si- -O -Si-R2 CH, R1 CH, CH,R 2 -Si- O- -Si-O Si- -O-Si-R 2 CH, R 1 CH, CH,
(H)
Figure imgf000009_0001
wobei die Reste R1 unabhängig voneinander eine lineare oder verzweigte CrC30-Alkylgruppe oder eine ggf. substituierte Phenylgruppe darstellen, die Reste R2 unabhängig voneinander die Gruppen -CcH2c-O-(C2H4O-)a(C3H6O-)bR5 oder
(H)
Figure imgf000009_0001
where the radicals R 1 independently of one another represent a linear or branched C r C 30 -alkyl group or an optionally substituted phenyl group, the radicals R 2 are independently of one another the groups -C c H 2c -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 or
-CcH2o-O-(C2H4O-)aR5 darstellen, die Reste R3 und R4 unabhängig voneinander eine lineare oder verzweigte C1-C16--C c H 2 o -O- (C 2 H 4 O-) a R 5 , the radicals R 3 and R 4 independently of one another represent a linear or branched C 1 -C 16 -
Alkylgruppe und bevorzugt Methylgruppen darstellen, die Reste R5 unabhängig voneinander ein Wasserstoffatom oder eine lineare oder verzweigte CrC16-Alkylgruppe und bevorzugt ein Wasserstoffatom oder eineAlkyl group and preferably methyl groups, the radicals R 5 are independently a hydrogen atom or a linear or branched C r C 16 alkyl group and preferably a hydrogen atom or a
Methylgruppe darstellen, m eine Zahl von 0 - 20 darstellt, n eine Zahl von O - 500 darstellt, o eine Zahl von 0 - 20 darstellt, p eine Zahl von 1 - 50 darstellt, a eine Zahl von 0 - 50 darstellt, b eine Zahl von 0 - 50 darstellt, a + b mindestens 1 sind, c eine Zahl von 1 - 4, besonders bevorzugt 3, darstellt, x eine Zahl von 1 - 100 darstellt. Eine erfindungsgemäß besonders bevorzugte Gruppe von Wasser-in-ÖI-Emulgatoren auf Siliconbasis sind die Poly-(C2-C3)alkylenglycol-modifizierten Silicone, deren frühere INCI-Bezeich- nung Dimethicone Copolyol lautete, mit den aktuellen INCI-Bezeichnungen PEG-x Dimethicone (mit x = 2 - 20, bevorzugt 3 - 17, besonders bevorzugt 11 - 12), Bis-PEG-y Dimethicone (mit y = 3 - 25, bevorzugt 4 - 20), PEG/PPG a/b Dimethicone (wobei a und b unabhängig voneinander für Zahlen von 2 - 30, bevorzugt 3 - 30 und besonders bevorzugt 12 - 20, insbesondere 14 - 18, stehen), Bis- PEG/PPG-c/d Dimethicone (wobei c und d unabhängig voneinander für Zahlen von 10 - 25, bevorzugt 14 - 20 und besonders bevorzugt 14 - 16, stehen) und Bis-PEG/PPG-e/f PEG/PPG g/h Dimethicone (wobei e, f, g und h unabhängig voneinander für Zahlen von 10 - 20, bevorzugt 14 - 18 und besonders bevorzugt 16, stehen). Besonders bevorzugt sind PEG/PPG-18/18 Dimethicone, das in einer 1 :9-Mischung mit Cyclomethicone als DC 3225 C bzw. DC 5225 C im Handel erhältlich ist, PEG/PPG-4/12 Dimethicone, das unter der Bezeichnung Abil B 8852 erhältlich ist, sowie Bis- PEG/PPG-14/14 Dimethicone, das in einer Mischung mit Cyclomethicone als Abil EM 97 (Goldschmidt) im Handel erhältlich ist, Bis-PEG/PPG-20/20 Dimethicone, das unter der Bezeichnung Abil B 8832 erhältlich ist, PEG/PPG-5/3 Trisiloxane (Silsoft 305), sowie PEG/PPG-20/23 Dimethicone (Silsoft 430 und Silsoft 440).Represents methyl, m is a number from 0-20, n is a number from O - 500, o is a number from 0-20, p is a number from 1-50, a is a number from 0-50, b is one Number represents from 0 to 50, a + b are at least 1, c represents a number from 1 to 4, particularly preferably 3, x represents a number from 1 to 100. A particularly preferred group of water-in-oil emulsifiers based on silicone according to the invention are the poly (C 2 -C 3 ) alkylene glycol-modified silicones whose former INCI name was dimethicone copolyol, with the current INCI names PEG- x dimethicones (with x = 2-20, preferably 3-17, more preferably 11-12), bis-PEG-y dimethicones (with y = 3-25, preferably 4-20), PEG / PPG a / b dimethicones ( where a and b independently of one another are numbers from 2 to 30, preferably 3 to 30 and more preferably 12 to 20, in particular 14 to 18), bis-PEG / PPG-c / d dimethicones (where c and d independently of one another Numbers from 10 to 25, preferably 14 to 20, and most preferably 14 to 16, and bis-PEG / PPG-e / f PEG / PPG g / h dimethicones (wherein e, f, g and h independently represent numbers of 10-20, preferably 14-18 and more preferably 16). Particular preference is given to PEG / PPG-18/18 dimethicones, which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C, PEG / PPG-4/12 dimethicone, sold under the name Abil B 8852 is available, as well as Bis-PEG / PPG-14/14 dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt), Bis-PEG / PPG-20/20 Dimethicone, under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440).
Weitere erfindungsgemäß bevorzugte W/O-Emulgatoren auf Siliconbasis sind Poly-(C2-C3)alkylen- glycol-modifizierte Silicone, die mit C4-Ci8-Alkylgruppen hydrophob modifiziert sind, besonders bevorzugt Cetyl PEG/PPG-10/1 Dimethicone (früher: Cetyl Dimethicone Copolyol, erhältlich als Abil EM 90 oder in einer Mischung aus Polyglyceryl-4-isostearat, Cetyl PEG/PPG-10/1 Dimethicone und Hexyllaurat unter der Handelsbezeichnung Abil WE 09), weiterhin Alkyl Methicone Copolyole und Alkyl Dimethicone Ethoxy Glucoside.Further according to the invention preferred W / O emulsifiers are silicone-based poly (C 2 -C 3) alkylene glycol-modified silicones which are modified with C 4 -C 8 alkyl hydrophobic, more preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: Cetyl Dimethicone Copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, Cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols and alkyl dimethicones Ethoxy Glucosides.
Unter den Organosiloxan-Oxyalkylen-Copolymeren als Wasser-in-ÖI-Emulgator auf Siliconbasis sind bestimmte Vertreter besonders bevorzugt.Among the organosiloxane-oxyalkylene copolymers as a water-in-oil emulsifier based on silicone, certain representatives are particularly preferred.
Erfindungsgemäß besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen- Copolymer der allgemeinen Strukturformel (I) enthalten, worin giltHair treatment agents which are particularly preferred according to the invention are characterized in that they comprise as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I) in which
R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5 mit a = 18, b = 18, c = 3, R5 = Methyl, n = 10 - 500, p = 10 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Dow Corning 190 (INCI: PEG/PPG-18/18 Dimethicone) erhältlich.R 1 = methyl, R 2 = -C c H 2 O -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 with a = 18, b = 18, c = 3, R 5 = methyl, n = 10 - 500, p = 10 - 50. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning 190 (INCI: PEG / PPG-18/18 Dimethicone).
Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen-Copolymer der allgemeinen Strukturformel (I) enthalten, worin giltFurther preferred hair treatment agents according to the invention are characterized in that they contain at least one organosiloxane-oxyalkylene copolymer as silicone-based water-in-oil emulsifier of the general structural formula (I), wherein
R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5 mit a = 12, b = 0, c = 3, R5 = Methyl, n = 10 - 500, p = 10 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Dow Corning 193 (INCI: PEG-12 Dimethicone) erhältlich.R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 with a = 12, b = 0, c = 3, R 5 = methyl, n = 10 - 500, p = 10 - 50. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning 193 (INCI: PEG-12 Dimethicone).
Erfindungsgemäß ebenfalls besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan- Oxyalkylen-Copolymer der allgemeinen Strukturformel (I) enthalten, worin gilt R1 = Methyl, R2 = -CcH2c-O-(C2H4O-)a(C3H6O-)bR5 mit a = 7, b = 0, c = 2, R5 = Methyl, n = 0, p = 1. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Silwet L-77 erhältlich.Also particularly preferred according to the invention hair treatment compositions are characterized in that they contain as a water-in-oil emulsifier silicone-based at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I), wherein R 1 = methyl, R 2 = -C c H2c -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 with a = 7, b = 0, c = 2, R 5 = methyl, n = 0, p = 1. Such an organosiloxane-oxyalkylene Copolymer is available, for example, under the trade name Silwet L-77.
Erfindungsgemäß insbesondere bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen- Copolymer der allgemeinen Strukturformel (I) enthalten, worin gilt R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5 mit a = 22, b = 24, c = 3, R5 = Methyl, n = 10 - 500, p = 10 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise in einer Mischung mit Cyclomethicone unter der Handelsbezeichnung Mirasil DCMO (INCI: Cyclomethicone, PEG/PPG-22/24 Dimethicone) erhältlich.Hair-treatment agents which are particularly preferred according to the invention are characterized in that they contain, as silicone-based water-in-oil emulsifier, at least one organosiloxane-oxyalkylene copolymer of general structural formula (I), where R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 θ-) a (C 3 H 6 O-) b R 5 where a = 22, b = 24, c = 3, R 5 = methyl, n = 10 - 500, p = 10 Such an organosiloxane-oxyalkylene copolymer is obtainable, for example, in a mixture with cyclomethicone under the trade name Mirasil DCMO (INCI: Cyclomethicone, PEG / PPG-22/24 Dimethicone).
Erfindungsgemäß besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen- Copolymer der allgemeinen Strukturformel (I) enthalten, worin gilt R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5mit a = 17, b = 18, c = 3, R5 = Methyl, n = 10 - 500, p = 10 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Dow Corning Q2-5220 (INCI: PEG/PPG-17/18 Dimethicone) erhältlich.Hair treatment agents which are particularly preferred according to the invention are characterized in that they contain as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of general structural formula (I), wherein R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 θ-) a (C 3 H 6 O-) b R 5 with a = 17, b = 18, c = 3, R 5 = methyl, n = 10 - 500, p = 10 - 50. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Dow Corning Q2-5220 (INCI: PEG / PPG-17/18 Dimethicone).
Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen-Copolymer der allgemeinen Strukturformel (I) enthalten, worin giltFurther preferred hair treatment agents according to the invention are characterized in that they contain as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I), wherein
R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5 mit a = 20, b = 6, c = 3, R5 = Methyl, n = 10 - 500, p = 5 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Abil B 88184 (INCI: PEG/PPG-20/6 Dimethicone) erhältlich. Erfindungsgemäß ebenfalls besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan- Oxyalkylen-Copolymer der allgemeinen Strukturformel (I) enthalten, worin gilt R1 = Methyl, R2 = - CcH2o-O-(C2H4θ-)a(C3H6O-)bR5 mit a = 14, b = 4, c = 3, R5 = Methyl, n = 10 - 500, p = 5 - 50. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Abil B 8851 (INCI: PEG/PPG-14/4 Dimethicone) erhältlich.R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 θ-) a (C 3 H 6 O-) b R 5 with a = 20, b = 6, c = 3, R 5 = methyl, n = 10 - 500, p = 5-50. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 88184 (INCI: PEG / PPG-20/6 Dimethicone). Also particularly preferred according to the invention hair treatment compositions are characterized in that they contain as a water-in-oil emulsifier silicone-based at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I), wherein R 1 = methyl, R 2 = - C c H applies 2o -O- (C 2 H 4 θ-) a (C 3 H 6 O-) b R 5 with a = 14, b = 4, c = 3, R 5 = methyl, n = 10 - 500, p = 5-50. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 8851 (INCI: PEG / PPG-14/4 Dimethicone).
Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen-Copolymer der allgemeinen Strukturformel (II) enthalten, worin giltFurther preferred hair treatment agents according to the invention are characterized in that they contain as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (II), wherein
R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5mit a = 14, b = 14, c = 3, R5 = Methyl, o = 0, n = 10R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 with a = 14, b = 14, c = 3, R 5 = methyl, o = 0, n = 10
- 500. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise in einer Mischung mit Cyclomethicone unter der Handelsbezeichnung Abil EM 97 (INCI: Bis-PEG/PPG-14/14 Dimethicone, Cyclomethicone) erhältlich.500. Such an organosiloxane-oxyalkylene copolymer is obtainable, for example, in a mixture with cyclomethicones under the trade name Abil EM 97 (INCI: Bis-PEG / PPG-14/14 Dimethicone, Cyclomethicone).
Erfindungsgemäß auch bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen-Copolymer der allgemeinen Strukturformel (II) enthalten, worin giltHair-treatment agents which are also preferred according to the invention are characterized in that they contain, as silicone-based water-in-oil emulsifier, at least one organosiloxane-oxyalkylene copolymer of the general structural formula (II) in which
R1 = Methyl, R2 = -CcH2o-O-(C2H4θ-)a(C3H6O-)bR5mit a = 20, b = 20, c = 3, R5 = Methyl, o = 0, n = 10R 1 = methyl, R 2 = -C c H 2o -O- (C 2 H 4 θ-) a (C 3 H 6 O-) b R 5 with a = 20, b = 20, c = 3, R 5 = methyl, o = 0, n = 10
- 500. Ein derartiges Organosiloxan-Oxyalkylen-Copolymer ist beispielsweise unter der Handelsbezeichnung Abil B 8832 (INCI: Bis-PEG/PPG-20/20 Dimethicone) erhältlich.500. Such an organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 8832 (INCI: Bis-PEG / PPG-20/20 Dimethicone).
Besonders bevorzugt sind die oben explizit angeführten Organosiloxan-Oxyalkylen-Copolymere der allgemeinen Strukturformel (I), die gegenüber den Organosiloxan-Oxyalkylen-Copolymeren der allgemeinen Strukturformel (II) eine bessere Wirkstofffreisetzung bewirken.Particularly preferred are the above explicitly mentioned organosiloxane-oxyalkylene copolymers of general structural formula (I) which provide better release of the active ingredient than the organosiloxane-oxyalkylene copolymers of general structural formula (II).
Weitere bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das Organosiloxan-Oxyalkylen-Copolymer bei 200C eine Wasserlöslichkeit von mindestens 5 g pro 100 g wässriger Lösung aufweist.Further preferred hair treatment compositions according to the invention are characterized in that the organosiloxane-oxyalkylene copolymer at 20 0 C has a water solubility of at least 5 g per 100 g of aqueous solution.
Weitere bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das Organosiloxan-Oxyalkylen-Copolymer einen HLB-Wert im Bereich von 8 - 20, bevorzugt 10 - 18, besonders bevorzugt 11 - 16 aufweist. Weitere bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß mindestens ein Organosiloxan-Oxyalkylen-Copolymer in einer Gesamtmenge von 0,01 - 5 Gew.-%, bevorzugt 0,1 - 4 Gew.-%, besonders bevorzugt in einer Gesamtmenge von 0,5 - 3 Gew.-%, außerordentlich bevorzugt in einer Gesamtmenge von 1 - 2 Gew.-%, enthalten ist, jeweils bezogen auf das Gesamtgewicht der (treibmittelfreien) Zusammensetzung.Further preferred hair treatment compositions according to the invention are characterized in that the organosiloxane-oxyalkylene copolymer has an HLB value in the range of 8-20, preferably 10-18, more preferably 11-16. Further preferred hair treatment compositions according to the invention are characterized in that at least one organosiloxane-oxyalkylene copolymer in a total amount of 0.01 to 5 wt .-%, preferably 0.1 to 4 wt .-%, particularly preferably in a total amount of 0.5 - 3 wt .-%, most preferably in a total amount of 1 - 2 wt .-%, is contained, each based on the total weight of the (propellant-free) composition.
Mit besonderem Vorzug können die erfindungsgemäßen Mittel zusätzlich mindestens einen Ölkörper enthalten. Der Einsatz von Ölkörpern verstärkt die erfindungsgemäßen Effekte, insbesondere den Glanz der mit den erfindungsgemäßen Mitteln behandelten Haare. Überraschenderweise wird zudem die Fülle weiter verbessert, obwohl eher eine Beschwerung zu erwarten wäre.With particular preference, the compositions according to the invention may additionally contain at least one oil body. The use of oil bodies enhances the effects according to the invention, in particular the gloss of the hair treated with the agents according to the invention. Surprisingly, the abundance is further improved, although more of a weighting would be expected.
Bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie 1 bis 20 Gew.-%, vorzugsweise 2,5 bis 17,5 Gew.-% und insbesondere 5 bis 12,5 Gew.-% mindestens eines Ölkörpers enthalten.Preferred hair treatment compositions according to the invention are characterized in that they contain 1 to 20 wt .-%, preferably 2.5 to 17.5 wt .-% and in particular 5 to 12.5 wt .-% of at least one oil body.
Erfindungsgemäß bevorzugte Ölkörper sind ausgewählt aus den Estern von linearen oder verzweigten gesättigten oder ungesättigten Fettalkoholen mit 2 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, die hydroxyliert sein können, den Benzoesäureestern von linearen oder verzweigten C8.22-Alkanolen, den C8-C22- Fettalkoholestern einwertiger oder mehrwertiger C2-C7-Hydroxycarbonsäuren, verzweigten gesättigten oder ungesättigten Fettalkoholen mit 6 - 30 Kohlenstoffatomen, Dicarbonsäureestern von linearen oder verzweigten C2-Ci0-Alkanolen, Di-n-alkylethern mit insgesamt 12 bis 36 Kohlenstoffatomen.Oil bodies which are preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated, the benzoic acid esters of linear or branched C 8 . 22 alkanols, the C 8 -C 22 - Fettalkoholestern monovalent or polyvalent C 2 -C 7 hydroxycarboxylic acids, branched saturated or unsaturated fatty alcohols having 6 - 30 carbon atoms, dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, di-n alkyl ethers having a total of 12 to 36 carbon atoms.
Die erfindungsgemäßen Haarbehandlungsmittel enthalten vorzugsweise mindestens ein Öl, ausgewählt aus den folgenden Gruppen:The hair treatment compositions according to the invention preferably comprise at least one oil selected from the following groups:
- den Estern von linearen oder verzweigten gesättigten oder ungesättigten Fettalkoholen mit 2 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, die hydroxyliert sein können. Dazu zählen bevorzugt 2-Ethylhexylpalmitat (z. B. Cegesoft® C 24), Hexyldecylstearat (Eutanol® G 16), Hexyldecyllaurat, Isodecylneopentanoat, Isononylisononanoat, 2-Ethylhexylstearat, Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropylisostearat, Isopropyloleat, Isooctylstearat, Isononylstearat, Isocetylstearat, Isononylisononanoat, Isotridecylisononanoat, Cetearylisononanot, 2-Ethylhexyllaurat, 2-Ethylhexylisostearat, 2-Ethylhexylcocoat, 2-Octyldodecylpalmitat, Butyloctansäure-2-butyloctanoat, Diisotridecylacetat, n- Butylstearat, n-Hexyllaurat, n-Decyloleat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat, Ethy- lenglycoldioleat und -dipalmitat sowie Mischungen hiervon;the esters of linear or branched saturated or unsaturated fatty alcohols having from 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having from 2 to 30 carbon atoms which may be hydroxylated. These include, preferably 2-ethylhexyl palmitate (z. B. Cegesoft ® C 24), hexyldecyl stearate (Eutanol ® G 16), hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, Isononylstearat, isocetyl stearate , Isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanot, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid 2-butyloctanoate, diisotridecylacetate, n- Butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate and mixtures thereof;
- den Benzoesäureestern von linearen oder verzweigten C8.22-Alkanolen, wobei C12-C15- Alkylbenzoate, z. B. das Handelsprodukt Finsolv® TN, Isostearylbenzoat, z. B. das Handelsprodukt Finsolv® SB, und Ethylhexylbenzoat, z. B. das Handelsprodukt Finsolv® EB, sowie Mischungen hiervon, besonders bevorzugt sind;- the benzoic acid esters of linear or branched C 8 . 22 -alkanols, wherein C 12 -C 15 - alkyl benzoates, z. B. the commercial product Finsolv ® TN, isostearyl benzoate, z. B. the commercial product Finsolv ® SB, and ethylhexyl benzoate, z. As the commercial product Finsolv ® EB, and mixtures thereof, are particularly preferred;
- den C8-C22-FeWaI koholestern einwertiger oder mehrwertiger C2-C7-Hydroxycarbonsäuren, besonders bevorzugt den Estern der Glycolsäure, Milchsäure, Äpfelsäure, Weinsäure, Citronen- säure und Salicylsäure sowie Mischungen hiervon. Besonders bevorzugte Ester auf Basis von linearen C12/15-Alkanolen, z. B. C12-C15-Alkyllactat, und von in 2-Position verzweigten C12/13-Alkano- len, z. B. Di-C12-C13-Alkylmalat, sind unter dem Warenzeichen Cosmacol® von der Firma Nordmann, Rassmann GmbH & Co, Hamburg, zu beziehen, insbesondere die Handelsprodukte Cosmacol® EMI, Cosmacol® ESI und Cosmacol® ETI;the C 8 -C 22 fatty alcohol esters of monohydric or polyhydric C 2 -C 7 hydroxycarboxylic acids, more preferably the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid and mixtures thereof. Particularly preferred esters based on linear C 12/15 alkanols, eg. B. C 12 -C 15 alkyl lactate, and of branched in the 2-position C 12/13 alkanols, z. For example, di-C 12 -C 13 alkyl malate, under the trademark Cosmacol ® by Nordmann, Rassmann GmbH & Co, Hamburg, refer, in particular the commercial products Cosmacol ® EMI, Cosmacol ® ESI and Cosmacol ® ETI;
- den verzweigten gesättigten oder ungesättigten Fettalkoholen mit 6 - 30 Kohlenstoffatomen. Diese Alkohole werden häufig auch als Guerbet-Alkohole bezeichnet, da sie nach der Guerbet-Reaktion erhältlich sind. Besonders bevorzugte Alkoholöle sind beispielsweise Hexyldecanol (z. B. Eutanol® G), Octyldodecanol und 2-Ethylhexylalkohol sowie Mischungen hiervon;- The branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction. Particularly preferred oils are alcohol thereof, for example, hexyl decanol (for example Eutanol ® G.), Octyl dodecanol, and 2-ethylhexyl alcohol, and mixtures thereof;
- Dicarbonsäureestern von linearen oder verzweigten C2-C10-Alkanolen, besonders bevorzugt Diiso- propyladipat, Di-n-butyladipat, Di-(2-ethylhexyl)adipat, Dioctyladipat, Diethyl-/Di-n-butyl/ Dioctyl- sebacat, Diisopropylsebacat, Dioctylmalat, Dioctylmaleat, Dicaprylylmaleat, Diisooctylsuccinat, Di- 2-ethylhexylsuccinat und Di-(2-hexyldecyl)-succinat sowie Mischungen hiervon;Dicarboxylic acid esters of linear or branched C 2 -C 10 alkanols, more preferably diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / dioctyl sebacate, Diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di (2-hexyldecyl) succinate, and mixtures thereof;
- Di-n-alkylethern mit insgesamt 12 bis 36, insbesondere 12 bis 24 C-Atomen, wobei Di-n-octylether (z. B. Cetiol® OE), Di-n-decylether, n-Hexyl-n-octylether und n-Octyl-n-decylether sowie Mischungen hiervon besonders bevorzugt sind.- Di-n-alkyl ethers having a total of 12 to 36, in particular 12 to 24 carbon atoms, wherein di-n-octyl ether (eg., Cetiol ® OE), di-n-decyl ether, n-hexyl n-octyl ether and n-octyl-n-decyl ethers and mixtures thereof are particularly preferred.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen Ester von linearen oder verzweigten gesättigten oder ungesättigten Fettalkoholen mit 2 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, der hydroxyliert sein kann, enthalten, der ausgewählt ist aus 2-Ethylhexylpalmitat, Hexyldecylstearat, Hexyldecyllaurat, Isodecylneopentanoat, Isononylisononanoat, 2-Ethylhexylstearat, Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Iso- propylisostearat, Isopropyloleat, Isooctylstearat, Isononylstearat, Isocetylstearat, Isononylisononanoat, Isotridecylisononanoat, Cetearylisononanot, 2-Ethylhexyllaurat, 2-Ethylhexylisostearat, 2-Ethyl- hexylcocoat, 2-Octyldodecylpalmitat, Butyloctansäure-2-butyloctanoat, Diisotridecylacetat, n-Butyl- stearat, n-Hexyllaurat, n-Decyloleat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat, Ethy- lenglycoldioleat und -dipalmitat sowie Mischungen hiervon.Particularly preferred hair treatment agents of the invention are characterized by containing at least one ester of linear or branched saturated or unsaturated fatty alcohols having from 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having from 2 to 30 carbon atoms which may be hydroxylated propylisostearat from 2-ethylhexyl palmitate, hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl, isopropyl oleate, isooctyl stearate, Isononylstearat, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, Cetearylisononanot, 2-ethylhexyl laurate, 2-ethylhexyl, 2 Ethyl hexyl cocoate, 2-octyl dodecyl palmitate, butyloctanoic acid 2-butyloctanoate, diisotridecyl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate and mixtures thereof.
Weitere besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen Benzoesäureester von linearen oder verzweigten C8_22- Alkanolen, ausgewählt aus C12-C15-Alkylbenzoaten, Isostearylbenzoat und Ethylhexylbenzoat sowie Mischungen hiervon, enthalten.Further particularly preferred hair treatment composition according to the invention are characterized in that they contain at least one benzoic acid esters of linear or branched C 8 _ 22 - of which alkanols selected from C 12 -C 15 alkyl benzoates, isostearyl benzoate and ethylhexyl benzoate and mixtures contain.
Weitere besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen C8-C22-Fettalkoholester einwertiger oder mehrwertiger C2-C7-Hydroxycarbonsäuren, ausgewählt aus den C8-C22-FeWaI koholestern der Glycolsäure, Milchsäure, Äpfelsäure, Weinsäure, Citronensäure und Salicylsäure sowie Mischungen hiervon, enthalten.Further particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one C 8 -C 22 fatty alcohol ester of monohydric or polyhydric C 2 -C 7 hydroxycarboxylic acids selected from the C 8 -C 22 fatty alcohol esters of glycolic acid, lactic acid, malic acid, tartaric acid , Citric acid and salicylic acid and mixtures thereof.
Weitere besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen verzweigten gesättigten oder ungesättigten Fettalkohol mit 6 - 30 Kohlenstoffatomen, ausgewählt aus Hexyldecanol, Octyldodecanol und 2-Ethylhexylalkohol sowie Mischungen hiervon, enthalten.Further particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one branched saturated or unsaturated fatty alcohol having 6 to 30 carbon atoms selected from hexyldecanol, octyldodecanol and 2-ethylhexyl alcohol and mixtures thereof.
Weitere besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen Dicarbonsäureester von linearen oder verzweigten C2- Cio-Alkanolen, ausgewählt aus Diisopropyladipat, Di-n-butyladipat, Di-(2-ethylhexyl)adipat, Dioctyl- adipat, Diethyl-/Di-n-butyl/Dioctylsebacat, Diisopropylsebacat, Dioctylmalat, Dioctylmaleat, Dicaprylyl- maleat, Diisooctylsuccinat, Di-2-ethylhexylsuccinat und Di-(2-hexyldecyl)-succinat sowie Mischungen hiervon, enthalten.Further particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one dicarboxylic acid ester of linear or branched C 2 -C 10 -alkanols selected from diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / Di-n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate, and mixtures thereof.
Weitere besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens einen Di-n-alkylether mit insgesamt 12 bis 36 Kohlenstoffatomen, ausgewählt aus Di-n-octylether, Di-n-decylether, n-Hexyl-n-octylether und n- Octyl-n-decylether sowie Mischungen hiervon, enthalten.Further particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one di-n-alkyl ether having a total of 12 to 36 carbon atoms selected from di-n-octyl ether, di-n-decyl ether, n-hexyl n-octyl ether and n-octyl -n-decyl ethers and mixtures thereof.
Ganz besonders bevorzugte erfindungsgemäße Mittel enthalten Isopropylmyristat. Insbesondere sind erfindungsgemäße Mittel bevorzugt, die 2,5 bis 20 Gew.-%, vorzugsweise 5 bis 15 Gew.-% und insbesondere 7,5 bis 11 ,0 Gew.-% Isopropylmyristat enthalten. Erfindungsgemäß besonders bevorzugte Mittel enthalten Isopropylmyristat und einen Wasser-in-ÖI- Emulgator auf Siliconbasis der FormelVery particularly preferred agents according to the invention contain isopropyl myristate. In particular, agents according to the invention which contain 2.5 to 20% by weight, preferably 5 to 15% by weight and in particular 7.5 to 11.0% by weight, of isopropyl myristate are preferred. Particularly preferred agents according to the present invention include isopropyl myristate and a silicone-based water-in-oil emulsifier of the formula
(H3C)3Si-O-[Si(CH3)(C3H 6-0-(C2H4θ-)18(C3H60-)15CH3)0-]1o.5o-[Si(CH3)2-0]1o.5oo-Si(CH3)3(H 3 C) 3 Si-O- [Si (CH 3) (C 3 H 6 -0- (C 2 H4θ-) 18 (C3H 6 0-) 15 CH 3) 0-] 1 o.5o- [Si (CH3) 2-0] 1 o.5oo-Si (CH3) 3
Die erfindungsgemäßen Mittel enthalten alle besagten Inhaltsstoffe in einem kosmetisch akzeptablen Träger.The agents according to the invention contain all said ingredients in a cosmetically acceptable carrier.
Übliche kosmetisch akzeptable Träger sind wässrige, alkoholische oder wässrigalkoholische Medien. Als Alkohole können insbesondere die für kosmetische Zwecke üblicherweise verwendeten niederen Alkohole mit 1 bis 4 Kohlenstoffatomen wie zum Beispiel Ethanol und Isopropanol enthalten sein.Common cosmetically acceptable carriers are aqueous, alcoholic or aqueous-alcoholic media. As alcohols, it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
Besonders bevorzugte erfindungsgemäße Mittel sind wasserarm oder gar wasserfrei formuliert. Insbesondere erfindungsgemäße Pflegeprodukte wie Haarspitzenfluids enthalten wenig bis kein Wasser. Generell sind erfindungsgemäß bevorzugte Haarbehandlungsmittel dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - weniger als 10 Gew.-%, vorzugsweise weniger als 7,5 Gew.-% weiter bevorzugt weniger als 5 Gew.-% und insbesondere weniger als 2,5 Gew.-% Wasser enthalten.Particularly preferred agents according to the invention are formulated with little or no water. In particular, care products according to the invention such as hair tip fluids contain little to no water. In general, preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, less than 10% by weight, preferably less than 7.5% by weight, more preferably less than 5% by weight and in particular less than 2.5 Wt .-% water.
Als zusätzliche Co-Solventien können organische Lösungsmittel oder ein Gemisch aus Lösungsmitteln mit einem Siedepunkt unter 4000C in einer Menge von 0,1 bis 15 Gewichtsprozent, bevorzugt von 1 bis 10 Gewichtsprozent bezogen auf das gesamte Mittel enthalten sein. Besonders geeignet als zusätzliche Co-Solventien sind un verzweigte oder verzweigte Kohlenwasserstoffe wie Pentan, Hexan, Isopentan und cyclische Kohlenwasserstoffe wie Cyclopentan und Cyclohexan. Weitere, besonders bevorzugte wasserlösliche Lösungsmittel sind Glycerin, Ethylenglykol , butylenglycol und Propylenglykol in einer Menge bis 30 Gew.-% bezogen auf das gesamte Mittel.As additional co-solvents, organic solvents or a mixture of solvents with a boiling point below 400 0 C in an amount of 0.1 to 15 weight percent, preferably from 1 to 10 weight percent be present on the total composition. Particularly suitable as additional co-solvents are un branched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane. Further, particularly preferred water-soluble solvents are glycerol, ethylene glycol, butylene glycol and propylene glycol in an amount of up to 30 wt .-% based on the total agent.
Ganz besonders bevorzugte erfindungsgemäße Mittel enthalten cyclische Dimethicone. Hier sind erfindungsgemäße Mittel bevorzugt, die zusätzlich mindestens ein Silikon der Formel Si-I Very particularly preferred agents according to the invention contain cyclic dimethicones. Here, agents according to the invention are preferred which additionally comprise at least one silicone of the formula Si-I
Figure imgf000017_0001
) enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von30 bis 7 und insbesondere 3, 4, 5 oder 6, steht.
Figure imgf000017_0001
) in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and especially 3, 4, 5 or 6.
Ganz besonders bevorzugte erfindungsgemäße Mittel enthalten - bezogen auf ihr Gewicht - 10 bis 80 Gew.-%, vorzugsweise 20 bis 77,5 Gew.-%, weiter bevorzugt 25 bis 76 Gew.-% und insbesondere 30 bis 75 Gew.-% Cyclopentasiloxan.Very particularly preferred compositions according to the invention contain, based on their weight, 10 to 80% by weight, preferably 20 to 77.5% by weight, more preferably 25 to 76% by weight and in particular 30 to 75% by weight of cyclopentasiloxane ,
Die erfindungsgemäßen Mittel können weiterhin die Hilfs- und Zusatzstoffe enthalten, die üblicherweise den jeweiligen kosmetischen Mitteln zugesetzt werden.The compositions of the invention may further contain the auxiliaries and additives which are usually added to the respective cosmetic products.
Als Pflegestoff einer anderen Verbindungsklasse kann das Mittel beispielsweise mindestens ein Proteinhydrolysat und/oder eines seiner Derivate enthalten. Das Molgewicht der erfindungsgemäß einsetzbaren Proteinhydrolysate liegt zwischen 75, dem Molgewicht für Glycin, und 200.000, bevorzugt beträgt das Molgewicht 75 bis 50.000 und ganz besonders bevorzugt 75 bis 20.000 Dalton.As a care substance of another class of compounds, the agent may contain, for example, at least one protein hydrolyzate and / or one of its derivatives. The molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
Erfindungsgemäß können Proteinhydrolysate sowohl pflanzlichen als auch tierischen oder marinen oder synthetischen Ursprungs eingesetzt werden. Tierische Proteinhydrolysate sind beispielsweise Elastin-, Kollagen-, Keratin-, Seiden- und Milcheiweiß-Proteinhydrolysate, die auch in Form von Salzen vorliegen können. Solche Produkte werden beispielsweise unter den Warenzeichen Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (Deutsche Gelatine Fabriken Stoess & Co), Lexein® (Inolex), Sericin (Pentapharm) und Kerasol® (Croda) vertrieben. Besonders interessant ist der Einsatz von Seiden-Proteinhydrolysaten. Unter Seide versteht man die Fasern des Kokons des Maulbeer-Seidenspinners (Bombyx mori L.). Die Rohseidenfaser besteht aus einem Doppelfaden Fibroin. Als Kittsubstanz hält Sericin diesen Doppelfaden zusammen. Seide besteht zu 70 - 80 Gew.% aus Fibroin, 19 - 28 Gew.% Sericin, 0,5 - 1 Gew.% aus Fett und 0,5 - 1 Gew.% aus Farbstoffen und mineralischen Bestandteilen. Proteinhydrolysate pflanzlichen Ursprungs, z. B. Soja-, Mandel-, Erbsen-, Kartoffel- und Weizenproteinhydrolysate, sind beispielsweise unter den Warenzeichen Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy (Croda), Hydrolupin (Croda), Hydrosesame (Croda), Hydrotritium® (Croda) und Crotein® (Croda) erhältlich.According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used. Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess and Co), Lexein ® (Inolex) sericin (Pentapharm) and kerasol tm ® (Croda) sold. Particularly interesting is the use of silk protein hydrolysates. By silk one understands the fibers of the cocoon of the mulberry silkworm (Bombyx mori L.). The raw silk fiber consists of a double thread fibroin. As a cement substance, sericin holds this double thread together. Silk consists of 70-80% by weight of fibroin, 19-28% by weight of sericin, 0.5-1% by weight of fat and 0.5-1% by weight of dyes and mineral constituents. Protein hydrolysates of vegetable origin, eg. As soybean, almond, pea, potato and wheat protein hydrolysates, for example, under the trademarks Gluadin ® (Cognis), DiaMin ® (Diamalt) ® (Inolex), Hydrosoy (Croda), hydro Lupine (Croda), hydro Sesame (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
Die Proteinhydrolysate sind in den erfindungsgemäßen Mitteln beispielsweise in Konzentrationen von 0,01 Gew.-% bis zu 20 Gew.-%, vorzugsweise von 0,05 Gew.-% bis zu 15 Gew.-% und ganz besonders bevorzugt in Mengen von 0,05 Gew.-% bis zu 5 Gew.-%, jeweils bezogen auf die gesamte Anwendungszubereitung enthalten.The protein hydrolysates are present in the agents according to the invention, for example, in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and very particularly preferably in amounts of 0 , 05 wt .-% up to 5 wt .-%, each based on the total application preparation included.
Als Pflegestoff einer anderen Verbindungsklasse sind weiterhin kationische Tenside geeignet.As a conditioner of another class of compounds continue cationic surfactants are suitable.
Erfindungsgemäß bevorzugt sind kationische Tenside vom Typ der quartären Ammoniumverbindungen, der Esterquats und der Amidoamine. Bevorzugte quartäre Ammoniumverbindungen sind Ammoniumhalogenide, insbesondere Chloride und Bromide, wie Alkyltrimethylammonium- chloride, Dialkyldimethylammoniumchloride und Trialkylmethylammoniumchloride, z.B. Cetyltri- methylammoniumchlorid, Stearyltrimethylammoniumchlorid, Distearyldimethylammoniumchlorid, Lau- ryldimethylammoniumchlorid, Lauryldimethylbenzylammoniumchlorid und Tricetylmethyl- ammoniumchlorid, sowie die unter den INCI-Bezeichnungen Quaternium-27 und Quaternium-83 bekannten Imidazolium-Verbindungen. Die langen Alkylketten der oben genannten Tenside weisen bevorzugt 10 bis 18 Kohlenstoffatome auf.Cationic surfactants of the quaternary ammonium compounds, esterquats and amidoamines type are preferred according to the invention. Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83. The long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
Bei Esterquats handelt es sich um bekannte Stoffe, die sowohl mindestens eine Esterfunktion als auch mindestens eine quartäre Ammoniumgruppe als Strukturelement enthalten. Bevorzugte Esterquats sind quaternierte Estersalze von Fettsäuren mit Triethanolamin, quaternierte Estersalze von Fettsäuren mit Diethanolalkylaminen und quaternierten Estersalzen von Fettsäuren mit 1 ,2- Dihydroxypropyldialkylaminen. Solche Produkte werden beispielsweise unter den Warenzeichen Stepantex®, Dehyquart® und Armocare® vertrieben. Die Produkte Armocare® VGH-70, ein N,N-Bis(2- Palmitoyloxyethyl)dimethylammoniumchlorid, sowie Dehyquart® F-75, Dehyquart® C-4046, Dehyquart® L80 und Dehyquart® AU-35 sind Beispiele für solche Esterquats.Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®. The products Armocare ® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats.
Die Alkylamidoamine werden üblicherweise durch Amidierung natürlicher oder synthetischer Fettsäuren und Fettsäureschnitte mit Dialkylaminoaminen hergestellt. Eine erfindungsgemäß besonders geeignete Verbindung aus dieser Substanzgruppe stellt das unter der Bezeichnung Tegoamid® S 18 im Handel erhältliche Stearamidopropyl-dimethylamin dar. Die kationischen Tenside sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05 bis 10 Gew.-%, bezogen auf die gesamte Anwendungszubereitung, enthalten. Mengen von 0,1 bis 5 Gew.-% sind besonders bevorzugt.The alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. An inventively particularly suitable compound from this group of substances under the name Tegoamid ® S 18 commercial stearamidopropyl dimethylamine is. The cationic surfactants are contained in the compositions according to the invention preferably in amounts of from 0.05 to 10% by weight, based on the total application preparation. Amounts of 0.1 to 5 wt .-% are particularly preferred.
Als Pflegestoff eignen sich ebenfalls pflegende Polymere. Es sei an dieser Stelle darauf hingewiesen, dass einige pflegende Polymere auch filmbildende und/oder festigende Eigenschaften aufweisen, und daher auch bei der Aufzählung geeigneter filmbildender und/oder festigender Polymere genannt sein können.Nurturing polymers are also suitable as a care substance. It should be noted at this point that some nourishing polymers also have film-forming and / or setting properties, and may therefore also be mentioned in the list of suitable film-forming and / or setting polymers.
Eine erste Gruppe der pflegenden Polymere sind die kationischen Polymere. Unter kationischen Polymeren sind Polymere zu verstehen, welche in der Haupt- und/oder Seitenkette eine Gruppe aufweisen, welche "temporär" oder "permanent" kationisch sein kann. Als "permanent kationisch" werden erfindungsgemäß solche Polymere bezeichnet, die unabhängig vom pH-Wert des Mittels eine kationische Gruppe aufweisen. Dies sind in der Regel Polymere, die ein quartäres Stickstoffatom, beispielsweise in Form einer Ammoniumgruppe, enthalten. Bevorzugte kationische Gruppen sind quartäre Ammoniumgruppen. Insbesondere solche Polymere, bei denen die quartäre Ammoniumgruppe über eine C^-Kohlenwasserstoffgruppe an eine aus Acrylsäure, Methacrylsäure oder deren Derivaten aufgebaute Polymerhauptkette gebunden sind, haben sich als besonders geeignet erwiesen.A first group of caring polymers are the cationic polymers. Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, such polymers in which the quaternary ammonium group are bonded via a C ^ -hydrocarbon group to a polymer main chain composed of acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
Homopolymere der allgemeinen Formel (G1-I),Homopolymers of the general formula (G1-I),
Figure imgf000019_0001
in der R1= -H oder -CH3 ist, R2, R3 und R4 unabhängig voneinander ausgewählt sind aus Ci_4-Alkyl-, - Alkenyl- oder -Hydroxyalkylgruppen, m = 1 , 2, 3 oder 4, n eine natürliche Zahl und X' ein physiologisch verträgliches organisches oder anorganisches Anion ist, sowie Copolymere, bestehend im wesentlichen aus den in Formel (G1-I) aufgeführten Monomereinheiten sowie nichtionogenen Monomereinheiten, sind besonders bevorzugte kationische Polymere. Im Rahmen dieser Polymere sind diejenigen erfindungsgemäß bevorzugt, für die mindestens eine der folgenden Bedingungen gilt: R1 steht für eine Methylgruppe; R2, R3 und R4 stehen für Methylgruppen; m hat den Wert 2. Als physiologisch verträgliche Gegenionen X' kommen beispielsweise Halogenidionen, Sulfationen, Phosphationen, Methosulfationen sowie organische Ionen wie Lactat-, Citrat-, Tartrat- und Acetationen in Betracht. Bevorzugt sind Halogenidionen, insbesondere Chlorid.
Figure imgf000019_0001
in which R 1 = -H or -CH 3, R 2, R 3 and R 4 are independently selected from CI_ 4 alkyl, - alkenyl or hydroxyalkyl groups, m = 1, 2, 3 or 4, n a natural number and X 'is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers. In the context of these polymers, those are preferred according to the invention for which at least one of the following conditions applies: R 1 is a methyl group; R 2 , R 3 and R 4 are methyl groups; m has the value 2. Suitable physiologically acceptable counterions X ' are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.
Ein besonders geeignetes Homopolymer ist das, gewünschtenfalls vernetzte, Poly(meth- acryloyloxyethyltrimethylammoniumchlorid) mit der INCI-Bezeichnung Polyquaternium-37. Die Vernetzung kann gewünschtenfalls mit Hilfe mehrfach olefinisch ungesättigter Verbindungen, beispielsweise Divinylbenzol, Tetraallyloxyethan, Methylen bisacrylamid, Diallylether, Polyallylpolyglycerylether, oder Allylethern von Zuckern oder Zuckerderivaten wie Erythritol, Pentaerythritol, Arabitol, Mannitol, Sorbitol, Sucrose oder Glucose erfolgen. Methylen bisacrylamid ist ein bevorzugtes Vernetzungsagens.A particularly suitable homopolymer is, if desired, crosslinked, poly (meth acryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylene bisacrylamide is a preferred crosslinking agent.
Das Homopolymer wird bevorzugt in Form einer nichtwässrigen Polymerdispersion, die einen Polymeranteil nicht unter 30 Gew.-% aufweisen sollte, eingesetzt. Solche Polymerdispersionen sind unter den Bezeichnungen Salcare® SC 95 (ca. 50 % Polymeranteil, weitere Komponenten: Mineralöl (INCI-Bezeichnung: Mineral OiI) und Tridecyl-polyoxypropylen-polyoxyethylen-ether (INCI- Bezeichnung: PPG-1-Trideceth-6)) und Salcare® SC 96 (ca. 50 % Polymeranteil, weitere Komponenten: Mischung von Diestern des Propylenglykols mit einer Mischung aus Capryl- und Caprinsäure (INCI-Bezeichnung: Propylene Glycol Dicaprylate/Dicaprate) und Tridecyl-polyoxy- propylen-polyoxyethylen-ether (INCI-Bezeichnung: PPG-1-Trideceth-6)) im Handel erhältlich.The homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth-6)) commercially available.
Copolymere mit Monomereinheiten gemäß Formel (G1-I) enthalten als nichtionogene Monomereinheiten bevorzugt Acrylamid, Methacrylamid, Acrylsäure-C^-alkylester und Methacrylsäure-C^- alkylester. Unter diesen nichtionogenen Monomeren ist das Acrylamid besonders bevorzugt. Auch diese Copolymere können, wie im Falle der Homopolymere oben beschrieben, vernetzt sein. Ein erfindungsgemäß bevorzugtes Copolymer ist das vernetzte Acrylamid-Methacryloyloxyethyltrimethyl- ammoniumchlorid-Copolymer. Solche Copolymere, bei denen die Monomere in einem Gewichtsverhältnis von etwa 20:80 vorliegen, sind im Handel als ca. 50 %ige nichtwäßrige Polymerdispersion unter der Bezeichnung Salcare® SC 92 erhältlich.Copolymers with monomer units of the formula (G1-I) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, acrylic acid C 1 -4 -alkyl esters and C 1 -4 -alkyl methacrylates. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. An inventively preferred copolymer is the crosslinked acrylamide-methacryloyloxyethyltrimethyl ammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
Weitere bevorzugte kationische Polymere sind beispielsweiseFurther preferred cationic polymers are, for example
- quaternisierte Cellulose-Derivate, wie sie unter den Bezeichnungen Celquat® und Polymer JR® im- Quaternized cellulose derivatives, as they are known under the names Celquat ® and Polymer JR ® im
Handel erhältlich sind. Die Verbindungen Celquat® H 100, Celquat® L 200 und Polymer JR®400 sind bevorzugte quaternierte Cellulose-Derivate, - kationische Alkylpolyglycoside gemäß der DE-PS 44 13 686,Trade are available. The compounds Celquat ® H 100, Celquat L 200 and Polymer JR ® ® 400 are preferred quaternized cellulose derivatives cationic alkyl polyglycosides according to DE-PS 44 13 686,
- kationisierter Honig, beispielsweise das Handelsprodukt Honeyquat® 50,- cationized honey, for example the commercial product Honeyquat ® 50,
- kationische Guar-Derivate, wie insbesondere die unter den Handelsnamen Cosmedia®Guar und Jaguar® vertriebenen Produkte,- cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ® Guar and Jaguar ®,
- Polysiloxane mit quartären Gruppen, wie beispielsweise die im Handel erhältlichen Produkte Q2- 7224 (Hersteller: Dow Corning; ein stabilisiertes Trimethylsilylamodimethicon), Dow Corning® 929 Emulsion (enthaltend ein hydroxyl-amino-modifiziertes Silikon, das auch als Amodimethicone bezeichnet wird), SM-2059 (Hersteller: General Electric), SLM-55067 (Hersteller: Wacker) sowie Abil®-Quat 3270 und 3272 (Hersteller: Th. Goldschmidt), diquaternäre Polydimethylsiloxane, Quaternium-80),Quaternary group polysiloxanes, such as the commercially available products Q2-72424 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® quat 3270 and 3272 (manufacturer: Th Goldschmidt.), diquaternary polydimethylsiloxanes, quaternium-80)
- polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure. Die unter den Bezeichnungen Merquat®100 (Poly(dimethyl- diallylammoniumchlorid)) und Merquat®550 (Dimethyldiallylammoniumchlorid-Acrylamid- Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere,- Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ® 100 (poly (dimethyl diallyl ammonium chloride)) and Merquat ® 550 (dimethyldiallylammonium chloride-acrylamide copolymer), commercially available products are examples of such cationic polymers,
- Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und - methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon- Dimethylaminoethylmethacrylat-Copolymere. Solche Verbindungen sind unter den Bezeichnungen Gafquat®734 und Gafquat®755 im Handel erhältlich,Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
- Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat® FC 370, FC 550, FC 905 und HM 552 angeboten werden,- vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ® FC 370, FC 550, FC 905 and HM 552,
- quaternierter Polyvinylalkohol,- quaternized polyvinyl alcohol,
- sowie die unter den Bezeichnungen Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 und Polyquaternium 27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette.- as well as the polymers known under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.
Gleichfalls als kationische Polymere eingesetzt werden können die unter den Bezeichnungen Polyquaternium-24 (Handelsprodukt z. B. Quatrisoft® LM 200), bekannten Polymere. Ebenfalls erfindungsgemäß verwendbar sind die Copolymere des Vinylpyrrolidons, wie sie als Handelsprodukte Copolymer 845 (Hersteller: ISP), Gaffix® VC 713 (Hersteller: ISP), Gafquat®ASCP 1011 , Gafquat®HS 110, Luviquat®8155 und Luviquat® MS 370 erhältlich sind.Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers. , Gaffix ® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
Weitere erfindungsgemäß einsetzbare kationische Polymere sind die so genannten "temporär kationischen" Polymere. Diese Polymere enthalten üblicherweise eine Aminogruppe, die bei bestimmten pH-Werten als quartäre Ammoniumgruppe und somit kationisch vorliegt. Bevorzugt sind beispielsweise Chitosan und dessen Derivate, wie sie beispielsweise unter den Handelsbezeichnungen Hydagen® CMF, Hydagen® HCMF, Kytamer® PC und Chitolam® NB/101 im Handel frei verfügbar sind.Further cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. Preferred are For example, chitosan and its derivatives, as they are freely available commercially, for example, under the trade names Hydagen ® CMF, Hydagen ® HCMF, Kytamer ® PC and Chitolam ® NB / 101.
Erfindungsgemäß bevorzugt eingesetzte kationische Polymere sind kationische Cellulose-Derivate und Chitosan und dessen Derivate, insbesondere die Handelsprodukte Polymer®JR 400, Hydagen® HCMF und Kytamer® PC, kationische Guar-Derivate, kationische Honig-Derivate, insbesondere das Handelsprodukt Honeyquat® 50, kationische Alkylpolyglycoside gemäß der DE-PS 44 13 686 und Polymere vom Typ Polyquaternium-37.According to the invention is preferably used cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ® 50, cationic Alkylpolyglycoside according to DE-PS 44 13 686 and polymers of the type Polyquaternium-37.
Weiterhin sind kationisierte Proteinhydrolysate zu den kationischen Polymeren zu zählen, wobei das zugrunde liegende Proteinhydrolysat vom Tier, beispielsweise aus Collagen, Milch oder Keratin, von der Pflanze, beispielsweise aus Weizen, Mais, Reis, Kartoffeln, Soja oder Mandeln, von marinen Lebensformen, beispielsweise aus Fischcollagen oder Algen, oder biotechnologisch gewonnenen Proteinhydrolysaten, stammen kann. Bevorzugt sind solche kationischen Proteinhydrolysate, deren zugrunde liegender Proteinanteil ein Molekulargewicht von 100 bis zu 25000 Dalton, bevorzugt 250 bis 5000 Dalton aufweist. Weiterhin sind unter kationischen Proteinhydrolysaten quaternierte Aminosäuren und deren Gemische zu verstehen. Die Quaternisierung der Proteinhydrolysate oder der Aminosäuren wird häufig mittels quartären Ammoniumsalzen wie beispielsweise N,N-Dimethyl-N- (n-Alkyl)-N-(2-hydroxy-3-chloro-n-propyl)-ammoniumhalogeniden durchgeführt. Weiterhin können die kationischen Proteinhydrolysate auch noch weiter derivatisiert sein. Als typische Beispiele für die erfindungsgemäßen kationischen Proteinhydrolysate und -derivate seien die unter den INCI - Bezeichnungen im "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17th Street, N.W., Suite 300, Washington, DC 20036-4702) genannten und im Handel erhältlichen Produkte genannt: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl/Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein/Siloxysilicate, Laurdimonium Hydroxypropyl Hydrolyzed Soy Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein/Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.Furthermore, cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 th Street, NW, Suite 300 Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiol in Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Lauridimonium Hydroxypropyl Hydrolyzed Soy Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurydimium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein , Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternaries ium-79 Hydrolyzed Wheat Protein.
Ganz besonders bevorzugt sind die kationischen Proteinhydrolysate und -derivate auf pflanzlicher Basis.Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.
Bevorzugt eingesetzte amphotere Polymere sind solche Polymerisate, die sich im wesentlichen zusammensetzen ausPreferably used amphoteric polymers are those polymers which are composed essentially
(a) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (Z-1 ), R1-CH=CR2-CO-Z-(CnH2n)-N(+)R3R4R5 A( ) (Z-1 ) in der R1 und R2 unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R3, R4 und R5 jeweils unabhängig voneinander für eine Alkylgruppe mit 1 bis 4 Kohlenstoffatomen, Z eine(a) monomers having quaternary ammonium groups of the general formula (Z-1), R 1 -CH = CR 2 -CO-Z- (C n H 2n ) -N (+) R 3 R 4 R 5 A () (Z -1) in which R 1 and R 2 are independently hydrogen or a methyl group and R 3 , R 4 and R 5 are each independently an alkyl group having 1 to 4 carbon atoms, Z is a
(-) NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und A das Anion einer organischen oder anorganischen Säure ist, und(-) NH group or an oxygen atom, n is an integer from 2 to 5 and A is the anion of an organic or inorganic acid, and
(b) monomeren Carbonsäuren der allgemeinen Formel (Z-2), R6-CH=CR7-COOH (Z-2) in denen R6 und R7 unabhängig voneinander für Wasserstoff oder eine Methylgruppe stehen.(b) monomeric carboxylic acids of the general formula (Z-2), R 6 -CH = CR 7 -COOH (Z-2) in which R 6 and R 7 independently of one another represent hydrogen or a methyl group.
Diese Verbindungen können sowohl direkt als auch in Salzform, die durch Neutralisation der Polymerisate, beispielsweise mit einem Alkalihydroxid, erhalten wird, erfindungsgemäß eingesetzt werden. Ganz besonders bevorzugt sind solche Polymerisate, bei denen Monomere des Typs (a) eingesetzt werden, bei denen R3, R4 und R5 Methylgruppen sind, Z eine NH-Gruppe und A( ) ein Halogenid-, Methoxysulfat- oder Ethoxysulfat-Ion ist; Acrylamidopropyltrimethyl-ammoniumchlorid ist ein besonders bevorzugtes Monomeres (a). Als Monomeres (b) für die genannten Polymerisate wird bevorzugt Acrylsäure verwendet. Die erfindungsgemäßen Mittel enthalten die pflegenden, kationischen und/oder amphoteren Polymere in bevorzugter Weise in einer Menge von 0,01 bis 5 Gew.-%, insbesondere in einer Menge von 0,1 bis 2 Gew.-%, jeweils bezogen auf die gesamte Anwendungszubereitung.These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention. Very particular preference is given to those polymers in which monomers of the type (a) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A () is a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (a). Acrylic acid is preferably used as monomer (b) for the stated polymers. The agents according to the invention preferably contain the caring, cationic and / or amphoteric polymers in an amount of from 0.01 to 5% by weight, in particular in an amount of from 0.1 to 2% by weight, in each case based on the total application preparation.
Weiter bevorzugte erfindungsgemäße Mittel sind dadurch gekennzeichnet, daß sie zusätzlich Pflegestoff(e) - bezogen auf ihr Gewicht - in Mengen von 0,001 bis 10 Gew.-%, vorzugsweise 0,005 bis 7,5 Gew.-%, besonders bevorzugt 0,01 bis 5 Gew.-% und insbesondere 0,05 bis 2,5 Gew.-% enthalten, wobei bevorzugte Pflegstoff(e) ausgewählt sind aus der Gruppe i. L-Carnitin und/oder seiner Salze; ii. Panthenol und/oder Panthothensäure; iii. der 2-Furanone und/oder deren Derivate, insbesondere Pantolacton; iv. Taurin und/oder seiner Salze; v. Niacinamid; vi. Ubichinon vii. Ectoin; viii. Allantoin.Further preferred agents according to the invention are characterized in that they additionally care substance (s) - in terms of their weight - in amounts of 0.001 to 10 wt .-%, preferably 0.005 to 7.5 wt .-%, particularly preferably 0.01 to 5 Wt .-% and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group i. L-carnitine and / or its salts; ii. Panthenol and / or panthothenic acid; iii. the 2-furanones and / or their derivatives, in particular pantolactone; iv. Taurine and / or its salts; v. niacinamide; vi. Ubiquinone vii. Ectoin; viii. Allantoin.
L-Carnitin (IUPAC-Name(R)-(3-Carboxy-2-hydroxypropyl)- Λ/,Λ/,Λ/-trimethylammoniumhydroxid), ist eine natürlich vorkommende, vitaminähnliche Substanz. Es spielt eine essentielle Rolle im Energiestoffwechsel menschlicher, tierischer und pflanzlicher Zellen. L-Carnitin kann über verschiedene Wege im industriellen Maßstab gewonnen werden. Beispielsweise über einen, die körpereigene Biosynthese imitierenden, biotechnologischen Prozess: In großen Fermentationsbehältern wird dabei die Vorstufe von L-Carnitin (γ-Butyrobetain) mit Hilfe von gramnegativen Bakterien (Rhizobien) in L-Carnitin umgesetzt.L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) - Λ /, Λ /, Λ / -trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance. It plays an essential role in the energy metabolism of human, animal and plant cells. L-carnitine can be obtained in various ways on an industrial scale. For example, a, the body's own biosynthesis imitating, biotechnological process: In large fermentation tanks while the precursor of L-carnitine (γ-butyrobetaine) using Gram-negative bacteria (rhizobia) in L-carnitine implemented.
Als Betain kann L-Carnitin Additionsverbindungen und Doppelsalze bilden. Erfindungsgemäß bevorzugte L-Carnitinderivate sind insbesondere ausgewählt aus Acetyl-L-Carnitin, L-Carnitin- Fumarat, L-Carnitin-Citrat, Lauroyl-L-Carnitin und besonderes bevorzugt L-Carnitin-Tartrat. Die genannten L-Carnitin-Verbindungen sind beispielsweise von der Firma Lonza GmbH (Wuppertal, Deutschland) erhältlich.As betaine, L-carnitine can form addition compounds and double salts. L-carnitine derivatives which are preferred according to the invention are selected in particular from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate. The L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).
Erfindungsgemäße bevorzugte Haarreinigungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht -0,001 bis 10 Gew.-%, vorzugsweise 0,005 bis 7,5 Gew.-%, besonders bevorzugt 0,01 bis 5 Gew.-% und insbesondere 0,05 bis 2,5 Gew.-% L-Carnitin oder L- Carnitinderivate enthalten, wobei bevorzugte L-Carnitinderivate ausgewählt sind aus Acetyl-L- Carnitin, L-Carnitin-Fumarat, L-Carnitin-Citrat, Lauroyl- L-Carnitin und insbesondere L-Carnitin- Tartrat.Preferred hair-cleansing compositions according to the invention are characterized in that they contain from -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight and in particular 0.05% by weight up to 2.5% by weight of L-carnitine or L-carnitine Carnitine derivatives containing preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.
Panthenol (ILJPAC-Name: (+)-(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramid) wird im Körper zu Pantothensäure umgewandelt. Pantothensäure ist ein Vitamin aus der Gruppe der B- Vitamine (Vitamin B5).Panthenol (ILJPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body. Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).
Erfindungsgemäße bevorzugte Haarreinigungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf sein Gewicht -0,01 bis 5 Gew.-%, vorzugsweise 0,05 bis 2,5 Gew.-%, besonders bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0,25 bis 1 Gew.-% Panthenol ((±)-2,4-Dihydroxy-Λ/- (3-hydroxypropyl)-3,3-dimethyl-butyramid) enthalten.Preferred hair-cleansing compositions according to the invention are characterized in that they contain -0.01 to 5% by weight, preferably 0.05 to 2.5% by weight, more preferably 0.1 to 1.5% by weight, based on their weight. % and in particular 0.25 to 1 wt .-% panthenol ((±) -2,4-dihydroxy-Λ / - (3-hydroxypropyl) -3,3-dimethyl-butyramide).
Erfindungsgemäß bevorzugte Haarreinigungsmittel enthalten - bezogen auf ihr Gewicht - 0,01 bis 15 Gew.-%, vorzugsweise 0,025 bis 12,5 Gew.-%, besonders bevorzugt 0,05 bis 10 Gew.-%, weiter bevorzugt 0,1 bis 7,5 Gew.-% und insbesondere 0,5 bis 5 Gew.-% mindestens eines 2- Furanonderivats der Formel (Fur-I) und/oder der Formel (Fur-Il)Hair cleansers preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II)
Figure imgf000025_0001
in welchen die Reste R1 bis R10 unabhängig voneinander stehen für:
Figure imgf000025_0001
in which the radicals R 1 to R 10 are independently of one another
Wasserstoff, -OH, einen Methyl-, Methoxy-, Aminomethyl- oder Hydroxymethylrest,Is hydrogen, -OH, a methyl, methoxy, aminomethyl or hydroxymethyl radical,
-C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen-C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear
Kohlenwasserstoffrest,Hydrocarbon radical,
-C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-,-C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-,
Di- oder Trihydroxykohlenwasserstoffrest,Di- or trihydroxyhydrocarbyl radical,
-C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-,-C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-,
Di- oder Triaminokohlenwasserstoffrest, eine Gruppe -OR11, mit R11 als einem -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oderDi- or triaminocarbon radical, a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated , branched or linear mono-, di- or
Trihydroxykohlenwasserstoffrest, eine Gruppe -NR12R13, wobei R12 und R13 jeweils unabhängig voneinander stehen für Wasserstoff, einen Methyl-, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, eine Gruppe -COOR14, wobei R14 steht für Wasserstoff, einen Methyl-, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C2 - C4 - gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triam inokohlenwasserstoffrest,Trihydroxykohlenwasserstoffrest, a group -NR 12 R 13 , wherein R 12 and R 13 each independently represent hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or Trihydroxykohlenwasserstoffrest, a group -COOR 14, wherein R 14 represents hydrogen, a methyl, a C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 - C 4 - saturated or on or diunsaturated, branched or linear mono, di or triamine hydrocarbon radical,
- eine Gruppe -CONR15R16, wobei R15 und R16 jeweils stehen für Wasserstoff, Methyl-, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C2 - C4 - gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triam inokohlenwasserstoffrest, eine Gruppe -COR16, wobei R16 steht für einen Methyl-, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest, eine Gruppe -OCOR17, wobei R17 steht für einen Methyl-, einen -C2 - C30 - gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C2 - C30 - gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Trioder Polyhydroxykohlenwasserstoffrest, einen -C2 - C30 - gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyaminokohlenwasserstoffrest, mit der Maßgabe, daß für den Fall, wenn R7 und R8 für -OH und gleichzeitig R9 oder R10 für Wasserstoff stehen, die verbleibende Gruppe R9 oder R10 nicht für einen Dihydroxyethylrest steht.- a group -CONR 15 R 16 , wherein R 15 and R 16 each represent hydrogen, methyl, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triamine inokohlenwasserstoffrest, a group -COR 16 , where R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbyl radical, a group -OCOR 17 , where i R 17 is a methyl, C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear mono -, di-, trihydrocarbyl, a -C 2 - C 30 - saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical, with the proviso that for the case when R 7 and R 8 is -OH and at the same time R 9 or R 10 is hydrogen, the remaining group R 9 or R 10 is not a dihydroxyethyl radical.
In einer weiteren Ausführungsform der erfindungsgemäßen Lehre hat es sich gezeigt, daß bei den Verbindungen der Formel (Fur-I) oder der Formel (Fur-Il) die Reste R3, R4 und R8 bevorzugt unabhängig voneinander stehen für:In a further embodiment of the teaching according to the invention, it has been found that, in the case of the compounds of the formula (Fur-I) or of the formula (Fur-II), the radicals R 3 , R 4 and R 8 are preferably independently of one another
- Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest, - einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
- einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder- a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
- einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.- a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or Triaminokohlenwasserstoffrest.
Weiterhin kann es bevorzugt sein, wenn in dem erfindungsgemäßen Wirkstoff gemäß der Formel(Fur- I) und/oder der Formel(Fur-ll) für die Reste R5, R6, R9 und R10 unabhängig voneinander stehen für:It may furthermore be preferred for the radicals R 5 , R 6 , R 9 and R 10 in the active substance according to the formula (Fur I) and / or the formula (Fur II) according to the invention to be independently of one another
- Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
- einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
- einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder- a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
- einen -C2 - C4 - gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.- a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or Triaminokohlenwasserstoffrest.
In einer besonders bevorzugten Ausführungsform der erfindungsgemäßen Lehre wird als Verbindung entsprechend der Formel (Fur-I) (R)-(-)-4-Hydroxymethyl-T-butyrolacton und/oder D,L-4- Hydroxymethyl-γ-butyrolacton und/oder (S)-(+)-4-Hydroxymethyl-γ^butyrolacton und/oder R-(-)-2- Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder D,L-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder S(+)-2-Hydroxy-3,3-dimethyl-γ^butyrolacton und/oder 4-Hydroxy-2,5-dimethyl-3(2H)-furanon und/oder Tetrahydro-5-oxo-2-furancarbonsäure und/oder Tetrahydro-5-oxo-2-furancarbonsäure, Na-SaIz und/oder Tetrahydro-5-oxo-2-furancarbonsäure, K-SaIz und/oder 2,5-Dihydro-5-methoxy-2-furanon und/oder Dihydro-3-hydroxy-4,4-dimethyl-2(3/-/)-furanon eingesetzt. In einer ganz besonders bevorzugten Ausführungsform der erfindungsgemäßen Lehre wird als Verbindung entsprechend der Formel (Fur-I) Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanon eingesetzt.In a particularly preferred embodiment of the teaching according to the invention, the compound corresponding to the formula (Fur-I) is (R) - (-) - 4-hydroxymethyl-T-butyrolactone and / or D, L-4-hydroxymethyl-γ-butyrolactone and / or (S) - (+) - 4-hydroxymethyl-γ-butyrolactone and / or R - (-) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or D, L-2-hydroxy-3 , 3-dimethyl-γ-butyrolactone and / or S (+) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or 4-hydroxy-2,5-dimethyl-3 (2H) -furanone and / or tetrahydro-5-oxo-2-furancarboxylic acid and / or tetrahydro-5-oxo-2-furancarboxylic acid, Na-SaIz and / or tetrahydro-5-oxo-2-furancarboxylic acid, K-salt and / or 2,5-dihydro -5-methoxy-2-furanone and / or dihydro-3-hydroxy-4,4-dimethyl-2 (3 / - /) - furanone used. In a very particularly preferred embodiment of the teaching according to the invention is used as a compound corresponding to the formula (Fur-I) dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone.
Ein weiterer, bevorzugter einsetzbarer Pflege-Enhancer, der aktivierende Eigenschaften besitzt, ist das Taurin. Erfindungsgemäß bevorzugte Haarreinigungsmittel enthalten - bezogen auf ihr Gewicht - 0,01 bis 15 Gew.-%, vorzugsweise 0,025 bis 12,5 Gew.-%, besonders bevorzugt 0,05 bis 10 Gew.-%, weiter bevorzugt 0,1 bis 7,5 Gew.-% und insbesondere 0,5 bis 5 Gew.-% Taurin (2- Aminoethansulfonsäure). Eine weitere bevorzugte Gruppe von Pflege-Enhancerm in den erfindungsgemäßen Mitteln sind Vitamine, Provitamine oder Vitamin Vorstufen. Bevorzugt enthalten die erfindungsgemäßen Mittel Vitamine, Provitamine und Vitaminvorstufen aus den Gruppen A, B, C, E und H. Panthenol, Pantolacton, Pyridoxin und seine Derivate sowie Nicotinsäureamid und Biotin sind besonders bevorzugt. Ganz besonders bevorzugt wird als Pflegestoff D-Panthenol, gegebenenfalls in Kombination mit mindestens einem der oben genannten Silikonderivate eingesetzt.Another preferred care enhancer which has activating properties is taurine. Hair cleansers preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid). Another preferred group of skin care enhancers in the compositions of the invention are vitamins, provitamins or vitamin precursors. The agents according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, C, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinamide and biotin are particularly preferred. Very particular preference is given to using D-panthenol as care substance, if appropriate in combination with at least one of the abovementioned silicone derivatives.
Es hat sich gezeigt, daß bestimmte Chinone eine besondere Eignung als Pflege-Enhancer besitzen. Besonders eignen sich erfindungsgemäße Mittel mit Pflegewirkung, die als Pflegestoff - bezogen auf ihr Gewicht - 0,0001 bis 1 Gew.-%, bevorzugt 0,001 bis 0,5 Gew.-% und besonders bevorzugt 0,005 bis 0,1 Gew.-% mindestens eines Ubichinons und/oder mindestens eines Ubichinols und/oder mindestens eines Derivates dieser Substanzen enthalten, wobei bevorzugte Mittel ein Ubichinon der Formel (Ubi) enthaltenIt has been shown that certain quinones have particular suitability as a care enhancer. Particularly suitable agents according to the invention with a care effect, the care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% at least a ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
Figure imgf000028_0001
in der n für die Werte = 6, 7, 8, 9 oder 10, besonders bevorzugt für 10 (Coenzym Q10) steht.
Figure imgf000028_0001
in which n stands for the values = 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
Als weiteren Pflege-Enhacer können die erfindungsgemäßen Mittel Ectoin enthalten. Ectoin ((4S)-2- Methyl-1 ,4,5,6-Tetrahydropyrimidin-4-Carbonsäure) ist ein zur Gruppe der kompatiblen Solute gehörender Naturstoff. Erfindungsgemäße Mittel können bevorzugt - bezogen auf dessen Gewicht - 0,001 bis 10 Gew.-%, vorzugsweise 0,01 bis 5 Gew.-%, besonders bevorzugt 0,05 bis 2,5 Gew.-% und insbesondere 0,1 bis 1 Gew.-% (S)-2-Methyl-1 ,4,5,6-tetrahydro-4-pyrimidincarbonsäure (Ectoin) sowie die physiologisch verträglichen Salze dieser Verbindung und/oder (S,S)-5-Hydroxy-2-methyl- 1 ,4,5,6-tetrahydro-4-pyrimidincarbonsäure (Hydroxyectoin) sowie die physiologisch verträglichen Salze dieser Verbindung, enthalten.As a further care enhancer, the agents according to the invention may contain ectoin. Ectoine ((4S) -2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes. Agents according to the invention may preferably contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1% by weight .-% (S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically acceptable salts of this compound and / or (S, S) -5-hydroxy-2-methyl - 1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (hydroxyectoine) and the physiologically acceptable salts of this compound.
Ein weitrer Pflege-Enhancer ist Allantoin. Das Allantoin (5-Ureidohydantoin, Λ/-(2,5-Dioxo-4- imidazolidinyl)-harnstoff) ist bei verschiedenen Tierarten, vor allem bei Säugetieren, neben der Harnsäure das Endprodukt des Abbaus von Nukleinsäuren, speziell von Purinbasen. Erfindungsgemäße Mittel enthalten optional - bezogen auf ihr Gewicht - 0,001 bis 10 Gew.-%, vorzugsweise 0,01 bis 5 Gew.-%, besonders bevorzugt 0,05 bis 2,5 Gew.-% und insbesondere 0,1 bis 1 Gew.-% 5-Ureidohydantoin (Allantoin).Another nurse enhancer is allantoin. Allantoin (5-ureidohydantoin, Λ / - (2,5-dioxo-4-imidazolidinyl) urea) is the final product of nucleic acid degradation, especially of purine, in various animal species, especially mammals, in addition to uric acid. Compositions according to the invention optionally contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1% by weight .-% 5-ureido-hydantoin (allantoin).
Zur Verbesserung der Elastizität und Festigung der inneren Struktur der mit erfindungsgemäßen Mitteln behandelter Haare können die erfindungsgemäßen Mittel Purin und/oder Purinderivate als Pflege-Enhancer enthalten. Insbesondere die Kombination von Purin und/oder Purinderivaten mit Ubichinonen und/oder Plastochinonen als Pflege-Enhancer führt dazu, daß die mit entsprechenden Mitteln behandelten Haare unter anderem höhere Meßwerte bei der Differenzthermoanalyse und verbesserte Naß- und Trockenkämmbarkeiten zeigen.To improve the elasticity and strengthen the internal structure of the hair treated with the agents according to the invention, the compositions according to the invention may contain purine and / or purine derivatives as care-enhancing agents. In particular, the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones as skin care enhancers means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.
Purin (7/-/-lmidazo[4,5-d]pyrimidin) kommt frei in der Natur nicht vor, bildet jedoch den Grundkörper der Purine. Purine ihrerseits sind eine Gruppe wichtiger, in der Natur weit verbreiteter und an menschlichen, tierischen, pflanzlichen und mikrobiellen Stoffwechselvorgängen beteiligter Verbindungen, die sich vom Grundkörper durch Substitution mit OH, NH2, SH in 2-, 6- und 8-Stellung und/oder mit CH3 in 1 -, 3-, 7-Stellung ableiten. Purin kann beispielsweise aus Aminoacetonitril und Formamid hergestellt werden. Purine und Purinderivate werden oft aus Naturstoffen isoliert, sind aber auch auf vielen Wegen synthetisch zugänglich.Purine (7 / - / - imidazo [4,5-d] pyrimidine) does not occur freely in nature, but forms the main body of purines. Purines, in turn, are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH 2 , SH at the 2-, 6-, and 8-positions and / or with CH 3 in 1, 3, 7 position. Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
Bevorzugte erfindungsgemäße Mittel enthalten Purin und/oder Purinderivate in engeren Mengenbereichen. Hier sind erfindungsgemäß bevorzugte kosmetische Mittel dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,001 bis 2,5 Gew.-%, vorzugsweise 0,0025 bis 1 Gew.-%, besonders bevorzugt 0,005 bis 0,5 Gew.-% und insbesondere 0,01 bis 0,1 Gew.-% Purin(e) und/oder Purinderivat(e) enthalten.Preferred agents according to the invention contain purine and / or purine derivatives in narrower quantitative ranges. Here are inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
Unter Purin, den Purinen und den Purinderivaten sind erfindungsgemäß einige Vertreter besonders bevorzugt. Erfindungsgemäß bevorzugte Haarreinigungsmittel sind dadurch gekennzeichnet, daß sie als Pflege-Enhancer - bezogen auf ihr Gewicht - 0,001 bis 2,5 Gew.-%, vorzugsweise 0,0025 bis 1 Gew.-%, besonders bevorzugt 0,005 bis 0,5 Gew.-% und insbesondere 0,01 bis 0,1 Gew.-% Purin(e) und/oder Purinderivat(e) enthält, wobei bevorzugte Mittel Purin und/oder Purinderivat(e) der Formel (Pur-I) enthalten Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. According to the invention preferred hair cleansers are characterized in that they are used as care enhancers - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt. % and in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s), wherein preferred agents purine and / or purine derivative (s) of the formula (Pur-I)
Figure imgf000030_0001
in der die Reste R1, R2 und R3 unabhängig voneinander ausgewählt sind aus -H, - OH, NH2, -SH und die Reste R4, R5 und R6 unabhängig voneinander ausgewählt sind aus -H, -CH3 und -CH2-CH3, wobei folgende Verbindungen bevorzugt sind: Purin (R1 = R2 = R3 = R4 = R5 = R6 = H), Adenin (R1 = NH2, R2 = R3 = R4 = R5 = R6 = H), Guanin (R1 = OH, R2 = NH2, R3 = R4 = R5 = R6 = H), Harnsäure (R1 = R2 = R3 = OH, R4 = R5 = R6 = H), Hypoxanthin (R1 = OH, R2 = R3 = R4 = R5 = R6 = H), 6-Purinthiol (R1 = SH, R2 = R3 = R4 = R5 = R6 = H), 6-Thioguanin (R1 = SH, R2 = NH2, R3 = R4 = R5 = R6 = H), Xanthin (R1 = R2 = OH, R3 = R4 = R5 = R6 = H), Coffein (R1 = R2 = OH, R3 = H, R4 = R5 = R6 = CH3), Theobromin (R1 = R2 = OH, R3 = R4 = H, R5 = R6 = CH3), Theophyllin (R1 = R2 = OH, R3 = H, R4 = CH3, R5 = CH3, R6 = H).
Figure imgf000030_0001
in which the radicals R 1 , R 2 and R 3 are independently selected from -H, - OH, NH 2 , -SH and the radicals R 4 , R 5 and R 6 are independently selected from -H, -CH 3 and -CH 2 -CH 3 , where the following compounds are preferred: purine (R 1 = R 2 = R 3 = R 4 = R 5 = R 6 = H), adenine (R 1 = NH 2 , R 2 = R 3 = R 4 = R 5 = R 6 = H), guanine (R 1 = OH, R 2 = NH 2 , R 3 = R 4 = R 5 = R 6 = H), uric acid (R 1 = R 2 = R 3 = OH, R 4 = R 5 = R 6 = H), hypoxanthine (R 1 = OH, R 2 = R 3 = R 4 = R 5 = R 6 = H), 6-purine thiol (R 1 = SH, R 2 = R 3 = R 4 = R 5 = R 6 = H), 6-thioguanine (R 1 = SH, R 2 = NH 2 , R 3 = R 4 = R 5 = R 6 = H), xanthine ( R 1 = R 2 = OH, R 3 = R 4 = R 5 = R 6 = H), caffeine (R 1 = R 2 = OH, R 3 = H, R 4 = R 5 = R 6 = CH 3 ) , Theobromine (R 1 = R 2 = OH, R 3 = R 4 = H, R 5 = R 6 = CH 3 ), theophylline (R 1 = R 2 = OH, R 3 = H, R 4 = CH 3 , R 5 = CH 3 , R 6 = H).
Als Pflege-Enhancer können die erfindungsgemäßen Mittel auch Flavonoide enthalten. Die Flavonoide sind eine Gruppe von wasserlöslichen Pflanzenfarbstoffen und spielen eine wichtige Rolle im Stoffwechsel vieler Pflanzen. Sie gehören zusammen mit den Phenolsäuren zu den Polyphenolen. Es sind weit über 6500 unterschiedliche Flavonoide bekannt, die sich in Flavonole, Flavone, Flavanone, Isoflavonoide und Anthocyane einteilen lassen.As a care enhancer, the agents according to the invention may also contain flavonoids. The flavonoids are a group of water-soluble plant dyes and play an important role in the metabolism of many plants. They belong together with the phenolic acids to the polyphenols. There are well over 6500 different flavonoids known, which can be divided into flavonols, flavones, flavanones, isoflavonoids and anthocyanins.
Erfindungsgemäß können Flavonoide aus allen sechs Gruppen eingesetzt werden, wobei bestimmte Vertreter aus den einzelnen Gruppen als Pflege-Enhancer wegen ihrer besonders intensiven Wirkung bevorzugt sind. Bevorzugte Flavonole sind Quercetin, Rutin, Kaempferol, Myricetin, Isorhamnetin, bevorzugte Flavanole sind Catechin, Gallocatechin, Epicatechin, Epigallocatechingallat , Theaflavin, Thearubigin, bevorzugte Flavone sind Luteolin, Apigenin, Morin, bevorzugte Flavanone sind Hesperetin, Naringenin, Eriodictyol, bevorzugte Isoflavonoide sind Genistein, Daidzein, und bevorzugte Anthocyanidine (Anthocyane) sind Cyanidin, Delphinidin, Malvidin, Pelargonidin, Peonidin, Petunidin.According to the invention, flavonoids from all six groups can be used, with certain representatives from the individual groups being preferred as care enhancers because of their particularly intensive action. Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin.
Weiterhin ist es erfindungsgemäß bevorzugt 2-Pyrrolidinon-5-carbonsäure und deren Derivate als Carbonsäure einzusetzen. Besonders bevorzugt sind die Natrium-, Kalium-, Calcium-, Magnesiumoder Ammoniumsalze, bei denen das Ammoniumion neben Wasserstoff eine bis drei Cr bis C4- Alkylgruppen trägt. Das Natriumsalz ist ganz besonders bevorzugt. Die eingesetzten Mengen in den erfindungsgemäßen Mitteln betragen vorzugsweise 0,05 bis 10 Gew.%, bezogen auf die gesamte Anwendungszubereitung, besonders bevorzugt 0,1 bis 5 Gew.%, und insbesondere bevorzugt 0,1 bis 3 Gew.%.Furthermore, it is inventively preferred to use 2-pyrrolidinone-5-carboxylic acid and derivatives thereof as the carboxylic acid. Particularly preferred are the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen one to three C r to C 4 - Carries alkyl groups. The sodium salt is most preferred. The amounts used in the compositions according to the invention are preferably from 0.05 to 10% by weight, based on the total application preparation, particularly preferably from 0.1 to 5% by weight, and particularly preferably from 0.1 to 3% by weight.
Durch Zugabe eines UV-Filters können sowohl die Mittel selbst, als auch die behandelten Fasern vor schädlichen Einflüssen von UV-Strahlung geschützt werden. Vorzugsweise wird daher dem Mittel mindestens ein UV-Filter zugegeben. Die erfindungsgemäß bevorzugten UV-Filter können beispielsweise ausgewählt werden aus substituierten Benzophenonen, p-Aminobenzoesäureestern, Diphenylacrylsäureestern, Zimtsäureestern, Salicylsäureestern, Benzimidazolen und o- Aminobenzoesäureestern. Die UV-Filter sind üblicherweise in Mengen von 0,01-5 Gew.-%, bezogen auf die gesamte Anwendungszubereitung, enthalten. Mengen von 0,1 -2,5 Gew.-% sind bevorzugt.By adding a UV filter, both the agents themselves and the treated fibers can be protected from the harmful effects of UV radiation. Preferably, therefore, at least one UV filter is added to the agent. The UV filters preferred according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters. The UV filters are usually contained in amounts of 0.01-5 wt .-%, based on the total application preparation. Amounts of 0.1-2.5 wt .-% are preferred.
In Abhängigkeit von der Art des erfindungsgemäßen Mittels kann es erforderlich sein, dass diese weiterhin mindestens ein Tensid enthalten. Dies gilt insbesondere für Haarreinigungsmittel und Shampoos. Aber auch andere Mittel, wie beispielsweise Haarspülungen, Haarkuren und bestimmte Stylingmittel, insbesondere Stylingschäume, können Tenside enthalten.Depending on the nature of the agent according to the invention, it may be necessary for them to further contain at least one surfactant. This is especially true for hair cleansers and shampoos. But other means, such as hair rinses, hair treatments and certain styling agents, in particular styling foams, may contain surfactants.
Beispielsweise können kationische Tenside eingesetzt werden, wie sie bereits oben als geeignete Pflegestoffe beschrieben sind. Bezüglich der bevorzugten kationischen Tenside und der eingesetzten Mengen gelten obige Ausführungen entsprechend.For example, cationic surfactants can be used, as described above as suitable care agents. With respect to the preferred cationic surfactants and the amounts used, the above statements apply accordingly.
Neben oder statt der kationischen Tenside können die Mittel weitere Tenside oder Emulgatoren enthalten, wobei prinzipiell sowohl anionische als auch ampholytische und nichtionische Tenside und alle Arten bekannter Emulgatoren geeignet sind. Die Gruppe der ampholytischen oder auch amphoteren Tenside umfasst zwitterionische Tenside und Ampholyte. Die Tenside können bereits emulgierende Wirkung haben.In addition to or instead of the cationic surfactants, the agents may contain other surfactants or emulsifiers, with both anionic and ampholytic and nonionic surfactants and all types of known emulsifiers being suitable in principle. The group of ampholytic or amphoteric surfactants includes zwitterionic surfactants and ampholytes. The surfactants may already have emulsifying effect.
Als anionische Tenside eignen sich prinzipiell alle für die Verwendung am menschlichen Körper geeigneten anionischen oberflächenaktiven Stoffe. Diese sind gekennzeichnet durch eine wasserlöslich machende, anionische Gruppe wie z. B. eine Carboxylat-, Sulfat-, Sulfonat- oder Phosphat-Gruppe und eine lipophile Alkylgruppe mit etwa 8 bis 30 C-Atomen. Zusätzlich können im Molekül Glykol- oder Polyglykolether-Gruppen, Ester-, Ether- und Amidgruppen sowie Hydroxylgruppen enthalten sein. Beispiele für geeignete anionische Tenside sind, jeweils in Form der Natrium- , Kalium- und Ammonium- sowie der Mono-, Di- und Trialkanolammoniumsalze mit 2 bis 4 C-Atomen in der Alkanolgruppe, lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen), Ethercarbonsäuren der Formel R-O-(CH2-CH2O)x-CH2-COOH, in der R eine lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist, Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe, Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe, Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe, Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen, lineare Alkansulfonate mit 8 bis 24 C-Atomen, lineare Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen, Alpha-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen, Alkylsulfate und Alkylpolyglykolethersulfate der Formel R-O(CH2-CH2O)x-OSO3H, in der R eine bevorzugt lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 12 ist, Gemische oberflächenaktiver Hydroxysulfonate, sulfatierte Hydroxyalkylpolyethylen- und/oder Hydroxyalkylen- propylenglykolether, Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen, Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2- 15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen, Alkyl- und/oder Alkenyletherphosphate der Formel (E1-I),Suitable anionic surfactants are in principle all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium and the mono-, di- and Trialkanolammoniumsalze with 2 to 4 carbon atoms in the alkanol group, linear and branched fatty acids having 8 to 30 carbon atoms (soaps), ether carboxylic acids of the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in the R is a linear alkyl group having 8 to 30 C. Atoms and x = 0 or 1 to 16, acylsarcosides having 8 to 24 carbon atoms in the acyl group, acyltaurides having 8 to 24 carbon atoms in the acyl group, acyl isethionates having 8 to 24 carbon atoms in the acyl group, sulfosuccinic mono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethyl esters having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 C-atoms, alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms, alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in the R is a preferably linear alkyl group having 8 to 30 C. Atoms and x = 0 or 1 to 12, mixtures of hydroxysulf surfactants onate, sulfated hydroxyalkylpolyethylene and / or hydroxyalkylene propylene glycol ethers, sulfonates of unsaturated fatty acids having 8 to 24 carbon atoms and 1 to 6 double bonds, esters of tartaric acid and citric acid with alcohols, the addition products of about 2-15 molecules of ethylene oxide and / or propylene oxide Fatty alcohols containing 8 to 22 carbon atoms, alkyl and / or alkenyl ether phosphates of the formula (E1-I),
O R1(OCH2CH2)n - O - P -OR2 (E1-I)OR 1 (OCH 2 CH 2 ) n - O - P --OR 2 (E1 - I)
II
OX in der R1 bevorzugt für einen aliphatischen Kohlenwasserstoffrest mit 8 bis 30 Kohlenstoffatomen, R2 für Wasserstoff, einen Rest (CH2CH2O)nR1 oder X, n für Zahlen von 1 bis 10 und X für Wasserstoff, ein Alkali- oder Erdalkalimetall oder NR3R4R5R6, mit R3 bis R6 unabhängig voneinander stehend für Wasserstoff oder einen C1 bis C4 - Kohlenwasserstoffrest, steht, sulfatierte Fettsäurealkylenglykolester der Formel (E1 -II)OX in the R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 1 or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6, independently of one another, represent hydrogen or a C 1 to C 4 hydrocarbon radical, is a sulfated fatty acid alkylene glycol ester of the formula (E1 -II)
R7CO(AIkO)nSO3M (EI -II) in der R7CO- für einen linearen oder verzweigten, aliphatischen, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 C-Atomen, Alk für CH2CH2, CHCH3CH2 und/oder CH2CHCH3, n für Zahlen von 0,5 bis 5 und M für ein Kation steht, wie sie in der DE-OS 197 36 906 beschrieben sind, Monoglyceridsulfate und Monoglyceridethersulfate der Formel (E1-III)R 7 CO (AIkO) n SO 3 M (EI-II) in the R 7 CO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms, Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n is from 0.5 to 5 and M is a cation, as described in DE-OS 197 36 906, monoglyceride sulfates and monoglyceride ether sulfates of the formula (E1-III )
CH2O(CH2CH2O)x — COR8 CH 2 O (CH 2 CH 2 O) x - COR 8
II
CHO(CH2CH2O)yHCHO (CH 2 CH 2 O) y H
II
CH2O(CH2CH2O)2-SO3X in der R8CO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen, x, y und z in Summe für O oder für Zahlen von 1 bis 30, vorzugsweise 2 bis 10, und X für ein Alkali- oder Erdalka- limetall steht, vorzugsweise werden Monoglyceridsulfate der Formel (E1 -III) eingesetzt, in der R8CO für einen linearen Acylrest mit 8 bis 18 Kohlenstoffatomen steht, Amidethercarbonsäuren, Kondensationsprodukte aus C8 - C30 - Fettalkoholen mit Proteinhydrolysaten und/oder Aminosäuren und deren Derivaten, welche dem Fachmann als Eiweissfettsäurekondensate bekannt sind, wie beispielsweise die Lamepon® - Typen, Gluadin® - Typen, Hostapon® KCG oder die Amisoft® - Typen.CH 2 O (CH 2 CH 2 O) 2 -SO 3 X in the R 8 CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for O or for numbers from 1 to 30, preferably 2 to 10, and X for an alkali or alkaline earth limetall is preferably monoglyceride sulfates of the formula (E1 -III) are used, in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms, amide ether carboxylic acids, condensation products of C 8 - C 30 - fatty alcohols with protein hydrolysates and / or amino acids and their derivatives, which are known to the skilled person as protein fatty acid condensates, such as Lamepon ® - types Gluadin ® - types Hostapon ® KCG or Amisoft ® - types.
Bevorzugte anionische Tenside sind Alkylsulfate, Alkylpolyglykolethersulfate und Ethercarbonsäuren mit 10 bis 18 C-Atomen in der Alkylgruppe und bis zu 12 Glykolethergruppen im Molekül, Sulfo- bernsteinsäuremono- und -dialkylester mit 8 bis 18 C-Atomen in der Alkylgruppe und Sulfobernstein- säuremono-alkylpolyoxyethylester mit 8 bis 18 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen, Monoglycerdisulfate, Alkyl- und Alkenyletherphosphate sowie Eiweissfettsäurekondensate.Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having from 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having from 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethyl esters with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and protein fatty acid condensates.
Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine -COO(~' - oder -SO3'"' - Gruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N-dimethylammonium-glycinate, beispielsweise das Kokosalkyl-dimethylammoniumgly- cinat, N-Acyl-aminopropyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosacylamino- propyl-dimethylammoniumglycinat, und 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethyl- carboxymethylglycinat. Ein bevorzugtes zwitterionisches Tensid ist das unter der INCI-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat.Zwitterionic surfactants are surface-active compounds which have in the molecule at least one quaternary ammonium group and at least one -COO (~ '- or -SO 3' '' - Wear group Particularly suitable zwitterionic surfactants are the betaines such as N-alkyl. N, N-dimethylammonium glycinates, for example the cocoalkyldimethylammonium glycineate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example the cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines The preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name cocamidopropyl betaine.
Unter Ampholyten werden solche oberflächenaktiven Verbindungen verstanden, die außer einer C8 - C24 - Alkyl- oder -Acylgruppe im Molekül mindestens eine freie Aminogruppe und mindestens eine - COOH- oder -SO3H-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete Ampholyte sind N-Alkylglycine, N-Alkylpropionsäuren, N-Alkylaminobuttersäuren, N- Alkyliminodipropionsäuren, N-Hydroxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsar- cosine, 2-Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe. Besonders bevorzugte Ampholyte sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropionat und das Ci2- Ci8 - Acylsarcosin.Ampholytes are understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts. Examples of suitable ampholytes are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group. Particularly preferred ampholytes are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 2 - C 8 - sarcosine.
Nichtionische Tenside enthalten als hydrophile Gruppe z.B. eine Polyolgruppe, eine Polyalkylenglykolethergruppe oder eine Kombination aus Polyol- und Polyglykolethergruppe. Solche Verbindungen sind beispielsweise Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 1 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und anNonionic surfactants contain, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group as the hydrophilic group. Such compounds are, for example Addition products of 2 to 50 moles of ethylene oxide and / or 1 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and on
Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, mit einem Methyl- oder C2 - C6 - Alkylrest endgruppenverschlossene Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 1 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Alkylphenols having 8 to 15 carbon atoms in the alkyl group, with a methyl or C 2 - C 6 - alkyl radical endgruppenverschlossene addition products of 2 to 50 moles of ethylene oxide and / or 1 to 5 moles of propylene oxide to linear and branched fatty alcohols with 8 to 30 C. Atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 carbon atoms.
Atomen in der Alkylgruppe, wie beispielsweise die unter den Verkaufsbezeichnungen Dehydol® LS,In the alkyl group atoms, such as those available under the brand names Dehydol ® LS
Dehydol® LT (Cognis) erhältlichen Typen,Dehydrol® ® LT types (Cognis),
Ci2-C30-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid anC 2 -C 30 fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide
Glycerin,glycerin,
Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
Polyolfettsäureester, wie beispielsweise das Handelsprodukt Hydagen® HSP (Cognis) oderPolyol fatty acid esters, such as the commercial product Hydagen ® HSP (Cognis) or
Sovermol - Typen (Cognis), alkoxilierte Triglyceride, alkoxilierte Fettsäurealkylester der Formel (E4-I)Sovermol types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of the formula (E4-I)
R1CO-(OCH2CHR2)WOR3 (E4-I) in der R1CO für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 Kohlenstoffatomen, R2 für Wasserstoff oder Methyl, R3 für lineare oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen und w für Zahlen von 1 bis 20 steht,R 1 CO- (OCH 2 CHR 2 ) W OR 3 (E4-I) in the R 1 CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R 2 is hydrogen or methyl, R 3 is linear or branched alkyl radicals having 1 to 4 carbon atoms and w is numbers from 1 to 20,
Aminoxide,Amine oxides,
Hydroxymischether, wie sie beispielsweise in der DE-OS 19738866 beschrieben sind,Hydroxymix ethers, as described for example in DE-OS 19738866,
Sorbitanfettsäureester und Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise die Polysorbate,Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,
Zuckerfettsäureester und Anlagerungsprodukte von Ethylenoxid an Zuckerfettsäureester,Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,
Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine,Addition products of ethylene oxide to fatty acid alkanolamides and fatty amines,
Zuckertenside vom Typ der Alkyl- und Alkenyloligoglykoside gemäß Formel (E4-II),Sugar surfactants of the alkyl and alkenyl oligoglycoside type of formula (E4-II),
R4O-[GJp (E4-II) in der R4 für einen Alkyl- oder Alkenylrest mit 4 bis 22 Kohlenstoffatomen, G für einen Zuckerrest mit 5 oder 6 Kohlenstoffatomen und p für Zahlen von 1 bis 10 steht. Sie können nach den einschlägigen Verfahren der präparativen organischen Chemie erhalten werden.R 4 O- [GJ p (E4-II) in which R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms, G is a sugar radical having 5 or 6 carbon atoms and p is a number from 1 to 10. They can be obtained by the relevant methods of preparative organic chemistry.
Bevorzugt sind Alkyloligoglucoside der Kettenlänge C8-Ci0 (DP = 1 bis 3), die als Vorlauf bei der destillativen Auftrennung von technischem C8-Ci8-Kokosfettalkohol anfallen und mit einem Anteil von weniger als 6 Gew.-% Ci2-AIkOhOl verunreinigt sein können sowie Alkyloligoglucoside auf Basis technischer Cg/n-Oxoalkohole (DP = 1 bis 3). Der Alkyl- bzw. Alkenylrest R15 kann sich ferner auch von primären Alkoholen mit 12 bis 22, vorzugsweise 12 bis 14 Kohlenstoffatomen ableiten. Typische Beispiele sind Laurylalkohol, Myristylalkohol, Cetylalkohol, Palmoleylalkohol, Stearylalkohol, Isostearylalkohol, Oleylalkohol, Elaidylalkohol, Petroselinylalkohol, Arachylalkohol, Gadoleylalkohol, Behenylalkohol, Erucylalkohol, Brassidylalkohol sowie deren technische Gemische, die wie oben beschrieben erhalten werden können. Bevorzugt sind Alkyloligoglucoside auf Basis von gehärtetem C12/i4-Kokosalkohol mit einem DP von 1 bis 3.Alkyl oligoglucosides of chain length of C 8 -C 0 (DP = 1 to 3), which are obtained as first runnings in the separation of technical C 8 -C 8 coconut oil fatty alcohol and having a content of less than 6 wt .-% Ci 2 - AIkOhOl can be contaminated and alkyl oligoglucosides based technical Cg / n-oxo alcohols (DP = 1 to 3). The alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms. Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol, and technical mixtures thereof which can be obtained as described above. Alkyl oligoglucosides based on hydrogenated C12 / i 4 coconut alcohol with a DP of 1 to 3
Als bevorzugte nichtionische Tenside haben sich die Alkylenoxid-Anlagerungsprodukte an gesättigte lineare Fettalkohole und Fettsäuren mit jeweils 2 bis 30 Mol Ethylenoxid pro Mol Fettalkohol bzw. Fettsäure erwiesen. Zubereitungen mit hervorragenden Eigenschaften werden ebenfalls erhalten, wenn sie als nichtionische Tenside Fettsäureester von ethoxyliertem Glycerin enthalten. Diese Verbindungen sind durch die folgenden Parameter gekennzeichnet. Der Alkylrest R enthält 6 bis 22 Kohlenstoffatome und kann sowohl linear als auch verzweigt sein. Bevorzugt sind primäre lineare und in 2-Stellung methylverzweigte aliphatische Reste. Solche Alkylreste sind beispielsweise 1-Octyl, 1-Decyl, 1-Lauryl, 1 -Myristyl, 1-Cetyl und 1-Stearyl. Besonders bevorzugt sind 1 -Octyl, 1- Decyl, 1-Lauryl, 1-Myristyl. Bei Verwendung sogenannter "Oxo-Alkohole" als Ausgangsstoffe überwiegen Verbindungen mit einer ungeraden Anzahl von Kohlenstoffatomen in der Alkylkette.The preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are identified by the following parameters. The alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals. Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl. When using so-called "oxo-alcohols" as starting materials, compounds with an odd number of carbon atoms in the alkyl chain predominate.
Bei den als Tensid eingesetzten Verbindungen mit Alkylgruppen kann es sich jeweils um einheitliche Substanzen handeln. Es ist jedoch in der Regel bevorzugt, bei der Herstellung dieser Stoffe von nativen pflanzlichen oder tierischen Rohstoffen auszugehen, so dass man Substanzgemische mit unterschiedlichen, vom jeweiligen Rohstoff abhängigen Alkylkettenlängen erhält.The compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.
Die weiteren Tenside werden in der Regel in Mengen von 0,1 bis 45 Gew.-%, bevorzugt 0,5 bis 30 Gew.-% und ganz besonders bevorzugt von 0,5 bis 25 Gew.-%, bezogen auf die jeweilige gesamte Zusammensetzung, eingesetzt. Dabei hängt die eingesetzte Menge wesentlich davon ab, welchen Zweck das erfindungsgemäße Mittel erfüllt.The other surfactants are generally in amounts of 0.1 to 45 wt .-%, preferably 0.5 to 30 wt .-% and most preferably from 0.5 to 25 wt .-%, based on the respective total Composition, used. The amount used depends essentially on the purpose of the agent according to the invention.
Die Mittel können neben den genannten Komponenten weiterhin alle für entsprechende kosmetische Mittel bekannten Wirk-, Zusatz- und Hilfsstoffe enthalten.In addition to the components mentioned, the agents may furthermore contain all active ingredients, additives and auxiliaries known for corresponding cosmetic agents.
Bezüglich weiterer fakultativer Komponenten sowie der eingesetzten Mengen dieser Komponenten wird ausdrücklich auf die dem Fachmann bekannten einschlägigen Handbücher verwiesen. BeispieleWith regard to further optional components and the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art. Examples
Folgende Zusammensetzung wurde durch mischen der jeweiligen Komponenten bereitgestellt:The following composition was provided by mixing the respective components:
Rohstoff Gew.-%Raw material weight%
Dow Corning 9040 1 22,00Dow Corning 9040 1 22.00
Dow Corning 5225 C 2 4,00Dow Corning 5225 C 2 4.00
Isopropylmyristat 9,00Isopropyl myristate 9.00
Seidenproteinhydrolysat 0,20Silk protein hydrolyzate 0.20
Arganöl 0,05Argan oil 0.05
Parfüm 0,30Perfume 0.30
Dow Corning 9045 3 Ad 100Dow Corning 9045 3 Ad 100
1 INCI-Bezeichnung: Cyclomethicone, Dimethicone Crosspolymer (gelförmige Mischung aus 90 Gew.-% Cyclomethicone & 10 Gew.-% vernetzem Silikonpolymer) (Dow Corning)1 INCI name: cyclomethicone, dimethicone crosspolymer (gel mixture of 90% by weight cyclomethicone & 10% by weight cross-linked silicone polymer) (Dow Corning)
2 INCI-Bezeichnung: Cyclomethicone, PEG/PPG-18/18 Dimethicone (Dow Corning)2 INCI name: Cyclomethicone, PEG / PPG-18/18 Dimethicone (Dow Corning)
3 INCI-Bezeichnung: Cyclomethicone, Dimethicone Crosspolmyer3 INCI name: Cyclomethicone, Dimethicone Crosspolmyer
Die resultierende Mischung wurde auf das Haar einer Testperson aufgetragen und im Haar belassen. Das Haar erhielt einen samtig weichen Griff und verlieh einen die Frisur strukturierenden Effekt ohne dabei beschwerend zu wirken. Das Haar der Testperson wurde nach erfolgter Bewertung mit einem herkömmlichen Shampoo gewaschen. Die obige Rezeptur war gut auswaschbar. The resulting mixture was applied to the hair of a subject and left in the hair. The hair received a velvety soft touch and gave the hairstyle structuring effect without being weight-bearing. The subject's hair was washed after evaluation with a conventional shampoo. The above recipe was easy to wash out.

Claims

Patentansprüche claims
1. Haarbehandlungsmittel, enthaltend in einem geeigneten kosmetischen Träger a) mindestens ein Siliconelastomer, das in einem Silicon-basierten Gel vorliegt, b) mindestens einen Wasser-in-ÖI-Emulgator auf Siliconbasis, dadurch gekennzeichnet, daß das Gewichtsverhältnis von Siliconelastomer a) zu Wasser-in-ÖI- Emulgator auf Siliconbasis b) größer als 1 ist.Hair treatment composition comprising, in a suitable cosmetic carrier a) at least one silicone elastomer present in a silicone-based gel, b) at least one water-in-oil emulsifier based on silicone, characterized in that the weight ratio of silicone elastomer a) to Silicon-based water-in-oil emulsifier b) greater than 1.
2. Haarbehandlungsmittel gemäß Anspruch 1 , dadurch gekennzeichnet, daß das Gewichtsverhältnis von Siliconelastomer a) zu Wasser-in-ÖI-Emulgator auf Siliconbasis b) im Bereich von 1 ,25 - 50, bevorzugt 1 ,5 - 30 und besonders bevorzugt 2 - 25, liegt.2. hair treatment composition according to claim 1, characterized in that the weight ratio of silicone elastomer a) to water-in-oil emulsifier silicone-based b) in the range of 1, 25- 50, preferably 1, 5-30 and particularly preferably 2-25 , lies.
3. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß das Siliconelastomere a) erhältlich ist durch die Vernetzung eines Organopolysiloxans, das mindestens 2 C2 - CiO-Alkenylgruppen mit terminaler Doppelbindung in jedem Molekül enthält, mit einem Organopolysiloxan, das mindestens 2 Silicon-gebundene Wasserstoffatome in jedem Molekül aufweist.3. hair treatment composition according to any one of the preceding claims, characterized in that the silicone elastomer a) is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 - Ci O -alkenyl groups having terminal double bond in each molecule, with an organopolysiloxane containing at least 2 Having silicon-bonded hydrogen atoms in each molecule.
4. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß das Siliconelastomere a) durch die Vernetzung eines Organopolysiloxans, das mindestens 2 C2 - Cio-Alkenylgruppen mit terminaler Doppelbindung in jedem Molekül enthält, mit mindestens einem alpha, omega-Dien erhältlich ist.4. Hair treatment composition according to one of the preceding claims, characterized in that the silicone elastomer a) is obtainable by crosslinking an organopolysiloxane which contains at least 2 C 2 - Cio-alkenyl groups having terminal double bond in each molecule, with at least one alpha, omega-diene ,
5. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß das Organopolysiloxan mit mindestens 2 C2 - Ci0-Al kenyl-Gruppen mit terminaler Doppelbindung im Molekül ausgewählt ist aus Methylvinylsiloxanen, Methylvinylsiloxan-Dimethylsiloxan- Copolymeren, Dimethylpolysiloxanen mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan- Methylphenylsiloxan-Copolymeren mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan- Diphenylsiloxan-Methylvinylsiloxan-Copolymeren mit Dimethylvinylsiloxy-Endgruppen, Dimethylsiloxan-Methylvinylsiloxan-Copolymeren mit Trimethylsiloxy-Endgruppen, Dimethyl- siloxan-Methylphenylsiloxan-Methylvinylsiloxan-Copolymeren mit Trimethylsiloxy-Endgruppen, Methyl-(3,3,3-trifluoropropyl)-polysiloxanen mit Dimethylvinylsiloxy-Endgruppen und Dimethylsil- oxan-Methyl-(3,3,3-trifluoropropyl)-siloxan-Copolymeren mit Dimethylvinylsiloxy-Endgruppen.5. Hair treatment composition according to one of the preceding claims, characterized in that the organopolysiloxane having at least 2 C 2 - Ci 0 -Al kenyl groups having terminal double bond in the molecule is selected from methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylpolysiloxanes with dimethylvinylsiloxy end groups, Dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, methyl (3 3, 3-trifluoropropyl) -polysiloxanes having dimethylvinylsiloxy end groups and dimethylsiloxane-methyl- (3,3,3-trifluoropropyl) -siloxane copolymers having dimethylvinylsiloxy end groups.
6. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß das vernetzende Organopolysiloxan mit mindestens zwei Silicon-gebundenen Wasserstoffatomen ausgewählt ist aus Methylhydrogenpolysiloxanen mit Trimethylsiloxy-Endgruppen, Dimethylsiloxan-Methylhydrogensiloxan-Copolymeren mit Trimethylsiloxy-Endgruppen und cyclischen Dimethylsiloxan-Methylhydrogen-Siloxan-Copolymeren.6. Hair treatment composition according to one of the preceding claims, characterized in that the crosslinking organopolysiloxane having at least two silicon-bonded hydrogen atoms is selected from methylhydrogenpolysiloxanes having trimethylsiloxy end groups, Dimethylsiloxane-methylhydrogensiloxane copolymers with trimethylsiloxy end groups and cyclic dimethylsiloxane-methylhydrogen-siloxane copolymers.
7. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es das/die Siliconelastomer(e) a), das/die in einem Silicon-basierten Gel vorlieg(t/en), in einer Gesamtmenge von 0,05 - 20 Gew.%, bevorzugt von 0,5 - 15 Gew.% und besonders bevorzugt von 1 - 12,5 Gew.%, jeweils bezogen auf die gesamte kosmetische Zusammensetzung, enthält.Hair treatment composition according to any one of the preceding claims, characterized in that it contains silicone elastomer (s) a) present in a silicone-based gel (t / s) in a total amount of 0.05-20 wt %, preferably from 0.5 to 15% by weight and particularly preferably from 1 to 12.5% by weight, in each case based on the total cosmetic composition.
8. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es als Wasser-in-ÖI-Emulgator auf Siliconbasis Organosiloxan-Oxyalkylen-Copolymer(e), ausgewählt aus Verbindungen der allgemeinen Strukturformeln (I), (II), (IM), (IV) und (V) enthält8. Hair treatment composition according to one of the preceding claims, characterized in that it is a water-in-oil emulsifier based on silicone organosiloxane-oxyalkylene copolymer (e) selected from compounds of the general structural formulas (I), (II), (IM) , (IV) and (V)
CH, CH3 CH, CH3 CH, CH 3 CH, CH 3
II
R -Si-O- -Si-O -Si O -Si-R CH3 CH, CH,R -Si-O- -Si-O -Si O -Si-R CH 3 CH, CH,
(I)(I)
Figure imgf000038_0001
wobei die Reste R1 unabhängig voneinander eine lineare oder verzweigte C1-C30-Al kylgruppe oder eine ggf. substituierte Phenylgruppe darstellen, • die Reste R2 unabhängig voneinander die Gruppen -CcH2c-O-(C2H4O-)a(C3H6O-)bR5 oder -CcH2o-O-(C2H4O-)aR5 darstellen,
Figure imgf000038_0001
where the radicals R 1 independently of one another represent a linear or branched C 1 -C 30 -alkyl group or an optionally substituted phenyl group, • the radicals R 2 are independently of one another the groups -C c H 2c -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 or -C c H 2o -O- (C 2 H 4 O-) a R 5 ,
• die Reste R3 und R4 unabhängig voneinander eine lineare oder verzweigte C1-C16- Alkylgruppe und bevorzugt Methylgruppen darstellen,The radicals R 3 and R 4 independently of one another represent a linear or branched C 1 -C 16 -alkyl group and preferably methyl groups,
• die Reste R5 unabhängig voneinander ein Wasserstoffatom oder eine lineare oder verzweigte CrC^-Alkylgruppe und bevorzugt ein Wasserstoffatom oder eine Methylgruppe darstellen,The radicals R 5 independently of one another represent a hydrogen atom or a linear or branched C 1 -C 4 -alkyl group and preferably represent a hydrogen atom or a methyl group,
• m eine Zahl von 0 - 20 darstellt,• m represents a number from 0 - 20,
• n eine Zahl von 0 - 500 darstellt,• n represents a number from 0 - 500,
• o eine Zahl von 0 - 20 darstellt,• o represents a number from 0 - 20,
• p eine Zahl von 1 - 50 darstellt,• p represents a number from 1 to 50,
• a eine Zahl von 0 - 50 darstellt,• a represents a number from 0 - 50,
• b eine Zahl von 0 - 50 darstellt,• b represents a number from 0 - 50,
• a + b mindestens 1 sind,• a + b are at least 1,
• c eine Zahl von 1 - 4, besonders bevorzugt 3, darstellt,C represents a number from 1 to 4, particularly preferred 3,
• x eine Zahl von 1 - 100 darstellt.• x represents a number from 1 - 100.
9. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass es als Wasser-in-ÖI-Emulgator auf Silikonbasis mindestens eine Verbindung der Formel (I) wie sie in Anspruch 6 definiert ist enthält.9. Hair treatment composition according to one of the preceding claims, characterized in that it contains as a water-in-oil emulsifier based on silicone at least one compound of formula (I) as defined in claim 6.
10. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es als Wasser-in-ÖI-Emulgator auf Siliconbasis mindestens ein Organosiloxan-Oxyalkylen- Copolymer der allgemeinen Strukturformel (I) enthält, worin gilt R1 = Methyl, R2 = -CcH2c-O- (C2H4θ-)a(C3H6O-)bR5mit a = 18, b = 18, c = 3, R5 = Methyl, n = 10 - 500, p = 10 - 50.10. Hair treatment composition according to one of the preceding claims, characterized in that it contains as water-in-oil emulsifier based on silicone at least one organosiloxane-oxyalkylene copolymer of the general structural formula (I), wherein R 1 = methyl, R 2 = - C c H 2c -O- (C 2 H 4 O-) a (C 3 H 6 O-) b R 5 with a = 18, b = 18, c = 3, R 5 = methyl, n = 10 - 500 , p = 10 - 50.
11. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass es zusätzlich mindestens ein Silikon der Formel Si-I11. Hair treatment composition according to one of the preceding claims, characterized in that it additionally contains at least one silicone of the formula Si-I
Figure imgf000039_0001
(Si-1 ) enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von 30 bis 7 und insbesondere 3, 4, 5 oder 6, steht.
Figure imgf000039_0001
(Si-1) in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and especially 3, 4, 5 or 6.
12. Haarbehandlungsmittel gemäß einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es 1 bis 20 Gew.-%, vorzugsweise 2,5 bis 17,5 Gew.-% und insbesondere 5 bis 12,5 Gew.- % mindestens eines Ölkörpers enthält. 12. Hair treatment composition according to one of the preceding claims, characterized in that it contains 1 to 20 wt .-%, preferably 2.5 to 17.5 wt .-% and in particular 5 to 12.5 wt .-% of at least one oil body.
PCT/EP2009/057423 2008-07-15 2009-06-16 Non-weighting hair treatment composition with structuring effects WO2010006866A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200810033106 DE102008033106A1 (en) 2008-07-15 2008-07-15 Non-weighty hair treatment product with structuring effects
DE102008033106.6 2008-07-15

Publications (2)

Publication Number Publication Date
WO2010006866A2 true WO2010006866A2 (en) 2010-01-21
WO2010006866A3 WO2010006866A3 (en) 2010-03-11

Family

ID=41393589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/057423 WO2010006866A2 (en) 2008-07-15 2009-06-16 Non-weighting hair treatment composition with structuring effects

Country Status (2)

Country Link
DE (1) DE102008033106A1 (en)
WO (1) WO2010006866A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912719B2 (en) 2014-10-20 2021-02-09 The Procter And Gamble Company Personal care composition and method of making
US10945935B2 (en) 2016-06-27 2021-03-16 The Procter And Gamble Company Shampoo composition containing a gel network
US11497691B2 (en) 2018-12-14 2022-11-15 The Procter & Gamble Company Shampoo composition comprising sheet-like microcapsules
WO2023040981A1 (en) * 2021-09-20 2023-03-23 Aegogen (Suzhou) Limited Methods and compositions for weight management
US11628126B2 (en) 2018-06-05 2023-04-18 The Procter & Gamble Company Clear cleansing composition
US11633072B2 (en) 2021-02-12 2023-04-25 The Procter & Gamble Company Multi-phase shampoo composition with an aesthetic design
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US11932448B2 (en) 2020-02-14 2024-03-19 The Procter & Gamble Company Bottle adapted for storing a liquid composition with an aesthetic design suspended therein

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971710B1 (en) * 2011-02-17 2014-07-04 Oreal USE OF POLYOXYALKYLENE (S) AND / OR POLYGLYCEROLE (S) ELASTOMERATED (S) SILICONE (S) IN AN AQUEOUS COMPOSITION FOR SHAPING KERATIN FIBERS
DE102011087233A1 (en) 2011-11-28 2013-05-29 Henkel Ag & Co. Kgaa Glossy hair treatment

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003342130A (en) * 2002-05-30 2003-12-03 Shiseido Co Ltd Hair cosmetic
EP1426027A1 (en) * 2001-09-14 2004-06-09 Shin-Etsu Chemical Company, Ltd. Composition and cosmetic preparation containing the same
EP1481660A1 (en) * 2003-05-26 2004-12-01 Shin-Etsu Chemical Co., Ltd. Cosmetic
EP1792640A1 (en) * 2005-12-02 2007-06-06 Wella Aktiengesellschaft Hair styling cream
EP1832275A2 (en) * 2006-03-03 2007-09-12 L'Oréal Hair styling compositions containing a silicone elastomer and a non-aqueous polar solvent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753968A (en) 1971-07-01 1973-08-21 Westvaco Corp Selective reaction of fatty acids and their separation
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (en) 1994-04-20 1996-10-24 Henkel Kgaa Cationic sugar surfactants, process for their preparation and their use
DE19736906A1 (en) 1997-08-25 1999-03-04 Henkel Kgaa Process for the preparation of sulfated fatty acid alkylene glycol esters
DE19738866A1 (en) 1997-09-05 1999-03-11 Henkel Kgaa Low-foaming surfactant mixtures with hydroxy mixed ethers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1426027A1 (en) * 2001-09-14 2004-06-09 Shin-Etsu Chemical Company, Ltd. Composition and cosmetic preparation containing the same
JP2003342130A (en) * 2002-05-30 2003-12-03 Shiseido Co Ltd Hair cosmetic
EP1481660A1 (en) * 2003-05-26 2004-12-01 Shin-Etsu Chemical Co., Ltd. Cosmetic
EP1792640A1 (en) * 2005-12-02 2007-06-06 Wella Aktiengesellschaft Hair styling cream
EP1832275A2 (en) * 2006-03-03 2007-09-12 L'Oréal Hair styling compositions containing a silicone elastomer and a non-aqueous polar solvent

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912719B2 (en) 2014-10-20 2021-02-09 The Procter And Gamble Company Personal care composition and method of making
US10945935B2 (en) 2016-06-27 2021-03-16 The Procter And Gamble Company Shampoo composition containing a gel network
US11628126B2 (en) 2018-06-05 2023-04-18 The Procter & Gamble Company Clear cleansing composition
US11497691B2 (en) 2018-12-14 2022-11-15 The Procter & Gamble Company Shampoo composition comprising sheet-like microcapsules
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US11932448B2 (en) 2020-02-14 2024-03-19 The Procter & Gamble Company Bottle adapted for storing a liquid composition with an aesthetic design suspended therein
US11633072B2 (en) 2021-02-12 2023-04-25 The Procter & Gamble Company Multi-phase shampoo composition with an aesthetic design
WO2023040981A1 (en) * 2021-09-20 2023-03-23 Aegogen (Suzhou) Limited Methods and compositions for weight management

Also Published As

Publication number Publication date
DE102008033106A1 (en) 2010-01-21
WO2010006866A3 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
WO2010006866A2 (en) Non-weighting hair treatment composition with structuring effects
EP2020227B1 (en) Cationic cellulose derivatives for cosmetics
EP2054020A1 (en) Cosmetic composition comprising purine and/or a purine derivative and taurine
DE102008034102A1 (en) Supple styling agent with a high degree of hold
DE102008020044A1 (en) Nourishing hair treatment procedure
DE102008045511A1 (en) Hair treatment preparations with low-dose oligopeptides
WO2009024359A1 (en) Hair treatment agent with conditioner(s) and melatonin/agomelatin
DE102011087621A1 (en) Hair treatment agent with 4-morpholinomethyl-substituted silicone (s) and thickener (s)
DE102009048299A1 (en) Hair treatment preparations containing surfactant (s) and proteolipid (s)
DE102008036075A1 (en) Nourishing hair cleanser with bioactive substances
DE102011087624A1 (en) "Hair treatment composition with 4-morpholinomethyl-substituted silicone (s) and conditioning agent (s)"
DE102008035172A1 (en) Structured composition with optimal storage stability properties
EP2717843B1 (en) Styling agents with an interesting texture
DE102007039741A1 (en) Hair treatment agent with surfactant (s) and melatonin / agomelatine
EP2164456A1 (en) Hair treatment agent containing oligo-peptides
DE102006056664A1 (en) Use of quercetin
DE102011087343A1 (en) Hair treatment agent with 4-morpholinomethyl-substituted silicone (s)
WO2009053180A1 (en) Cosmetic agent containing purine and/or a purine derivative and hydrogen peroxide
DE102007059705A1 (en) Hair cleanser with surfactant / care combination
WO2009024361A1 (en) Hair treatment compositions with alcohol(s) and melatonin/agomelatine
EP1961410A2 (en) Improved performance hair treatment agent for dandruff
DE102006002767A1 (en) Cosmetic agent useful for increasing the effectiveness of protective ultraviolet filters on the hair comprises a combination of a polysiloxane and an ester oil
DE102012206948A1 (en) Hair treatment agent with hydroxy-terminated organopolysiloxane (s) and thickener (s)
WO2007000223A1 (en) Cosmetic agent containing a polyammonium polysiloxane compound and additional active ingredients
DE102010043071A1 (en) Hair treatment agent containing 3-methyl-1,3-butanediol and alkylpolyglycoside (s)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09779776

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09779776

Country of ref document: EP

Kind code of ref document: A2